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Part 1 Introduction 
 
1 Introduction of Transition Metal-Catalyzed Direct C-H Bonds 
Functionalizations 
 
The carbon-hydrogen bonds (abbreviated as C-H bonds) are fundamental and 
most common chemical bonds in a variety of organic compounds. Owing to the high 
bond dissociation energy and the inertness of C-H bonds,
[1]
 e.g., 105 kcal/mol for 
H-CH3 and 110 kcal/mol for H-C6H5,
 
transformations of inert C-H bonds into C-C 
bonds or C-X bonds (X= S, O, N, Cl, Br, etc.) by metal catalysis are still great 
challenges nowadays. In general, traditional approaches for the transformations of 
C-H bonds rely on prefunctionalized starting materials for both reactivity and 
selectivity or require costly chemical steps. Thus, the development of a cheap and 
alternative method is still desirable to address the above issues. Transition 
metal-catalyzed direct functionalization of inert C-H bonds has attracted great 
attention and gradually emerged as a powerful method in organic synthesis. 
Compared with conventional approaches, the methodologies are environmental 
friendly and atom-economical and have been frequently applied in the synthesis of 
natural products, biologically active molecules and organic materials.  
In general, directing group-assisted transition metal-catalyzed C-H bond 
activation involves a five-membered cyclometalated key intermediate A (Scheme 1), 
which provides a favorable driving force in inducing reactivity at the desired location. 
Various directing groups have been utilized to activate C-H bonds by aid of transition 
metal catalysts, such as ruthenium, rhodium, palladium, iridium and other metal 
catalysts. 
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Scheme 1 General mechanism for directing group-assisted ortho-C-H activation 
 
 
 
Among all the transition metal catalysts, rhodium complexes are sustainable metal 
catalysts in the field of C-H activations. Despite the general high cost of rhodium 
complexes, rhodium catalysis will still be highly desirable if reaction systems are 
inaccessible under palladium or ruthenium catalysis. Indeed, the past decades have 
witnessed a dramatic development in the field. Rhodium-catalyzed directing 
group-assisted C-H activations and successive functionalization protocols have been 
extensively investigated. Very recently, rhodium(III) complexes, such as [RhCp
*
Cl2]2, 
[Cp
*
Rh(MeCN)3][BF4]2 and [Cp
*
Rh(MeCN)3][SbF6]2 have proved to be highly 
efficient catalysts in the field of direct C-H bonds functionalization. In this chapter, 
we will focus on rhodium-catalyzed C-H activations and subsequent functionalization 
reactions. 
 
1.1 Rhodium-Catalyzed C-H Activations and Subsequent 
Annulation Reactions 
 
Within the past decades, the oxidative activations of C-H/N-H or C-H/O-H bonds 
and subsequent annulation reactions with alkynes or alkenes have emerged as 
powerful methods for the synthesis of heterocyclic or carbocyclic compounds in 
metal-catalyzed organic synthesis. In general, these reactions proceed by 
chelation-assisted C-H bonds activations and oxidative additions of metal complexes 
to the ortho-C-H bonds, insertion of the alkynes or alkenes, reductive eliminations, 
and then annulations. These protocols have been utilized extensively for the 
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preparation of a wide range of substituted heterocyclic compounds such as indoles, 
isocumarines, isoquinolines, carbazoles, benzothiazoles and pyridines. In this part we 
will focus on Rh(III)-catalyzed annulation reactions and the involved mechanisms. 
   Satoh and Miura firstly reported a synthesis of polyarylated naphthyl and anthryl 
azole derivatives by direct coupling of phenyl azoles with internal alkynes in the 
presence of a rhodium catalyst and a copper oxidant (Scheme 2). The reaction 
involved the multiple C-H bonds cleavages and C-C bonds formations in a one-pot 
manner.
[2]
  
 
Scheme 2 Annulation of phenyl azoles with alkynes 
 
 
 
The authors proposed a mechanism initiated with the coordination between the 
N-atom and the Rh(III) species. Followed by a regioselective C-H activation, a 
rhodacycle A was formed. Successive direct insertion of an alkyne to the 
rhodium-carbon bond of the intermediate A afforded a seven-membered rhodacycle B. 
Then, a metallaindene C was formed by a second cyclometallation with the loss of an 
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HX. Subsequent insertion of a second alkyne into the Rh-C bond and successive 
reductive elimination gave the final product and a Rh(I) species, which was then 
oxidized to a Rh(III) species for the next cycle (Scheme 3). 
 
Scheme 3 Proposed mechanism 
 
 
 
Miura and coworkers also reported carboxylate group-assisted oxidative 
annulation reactions with internal alkynes. Benzoic acids reacted with internal alkynes 
in the presence of (Cp
*
RhCl2)2 and a stoichiometric amount of Cu(OAc)2H2O, 
affording the corresponding isocoumarin derivatives in high yields (5a and 5b in 
Scheme 4).
[3]
 Interestingly, a catalytic amount of Cu(OAc)2H2O with air or a 
stoichiometric amount of Cu(OAc)2H2O showed the same effect. Only in some cases, 
minor decarboxylative products (naphthalenes) were obtained (6a and 6b in Scheme 
4).
[3a]
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Scheme 4 Decarboxylative annulation of benzoic acids and alkynes 
 
    
Ketones are less coordinative to the rhodium complexes. However, Glorius and 
Cheng independently disclosed a successful oxidative annulation reaction between 
ketones and alkynes, which opened an easy access to substituted indenols (6a-d in 
Scheme 5) in various solvents such as PhCl and t-AmylOH.
[4] 
The catalytic reaction 
was highly regioselective with unsymmetrical alkynes. 
 
Scheme 5 Annulation of ketones and alkynes 
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Heterocyclic compounds such as substituted indoles are of great importance in the 
pharmaceutical area for being core structures of many commercial drugs. Numerous 
attempts in recent years have been made for the development of improved methods 
for the synthesis of heterocyclic compounds. In the context, Fagnou and coworkers 
reported a first Rh(III)-catalyzed annulation reaction of acetanilides with alkynes for 
the synthesis of substituted N-acyl indoles.
[5]
 The authors observed that no reaction 
took place when the reaction was carried out in the absence of the silver salt AgSbF6. 
Furthermore, Fagnou and coworkers developed a second generation 
rhodium(III)-catalyst [Cp
*
Rh(MeCN)3(SbF6)2], which was highly suitable under 
milder conditions (Scheme 6).
[6]
 Both systems showed good regioselectivities when 
asymmetric alkynes were applied. 
 
Scheme 6 Comparison of two generations of rhodium complexes 
 
 
 
In a similar manner, the same authors extended their reaction scope to conjugated 
enynes with N-aryl ureas, producing the desired substituted indoles in good yields 
under unprecedented mild conditions (Scheme 7).
[7]
 Interestingly, the methodology 
was also applicable for the synthesis of 2-alkenyl pyrroles (11c in Scheme 7) at room 
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temperature (condition B in Scheme ). 
 
Scheme 7 Annulation reaction of conjugated enynes with N-aryl ureas 
 
 
 
In 2010, Rakshit and Glorius reported an oxidative annulation reaction of 
enamines with alkynes for tetrasubstituted pyrroles 12 through an allylic C-H 
activation pathway via intermediate 14 (Scheme 8). However, the ester group was 
deduced to play a key role for the transformations (13a-c in Scheme 8).
[8]
 KIE 
experiment results showed a quick exchange of H/D at the α-position of the substrate. 
In some cases no desired products were obtained or they were formed in very low 
yields (13c in Scheme 8, 31% yield). However, when substrates with a CN group 
were applied in the failed cases, the desired products were isolated in good yields, e.g., 
13d in 72% yield (Scheme 8). This indicated that the CN group changed the pathway 
of the C-H activation. 
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Scheme 8 Oxidative annulation of enamines with alkynes 
 
 
 
Isoquinolone derivatives are important heterocyclic compounds and such types of 
skeletons are found in a wide range of natural products that show various biological 
activities. However, only few methods are available in the literature for the synthesis 
of isoquinolones. In most of these reactions, compounds with a carbon-halogen 
moiety were utilized as starting materials to generate the reactive species. Thus, 
protocols by direct C-H activations provide a good access to isoquinolones. To this 
end, Rh(III)-catalyzed annulation reaction of N-aryl benzamides with alkynes 
represented a promising method for the synthesis of isoquinolones. Miura
[9]
, Rovis
[10]
 
and Li
[11]
, independently reported isoquinolones synthetic routes under different 
reaction conditions (Scheme 9).  
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Scheme 9 Access to isoquinolones by annulation reactions 
 
 
 
Park and coworkers developed a Rh(III)-catalyzed intramolecular C-H activation 
and subsequent annulation reaction of alkyne-tethered hydroxamic acid esters. This 
protocol provided a great opportunity for the synthesis of substituted isoquinolones in 
good yields with excellent regioselectivity.
[12]
 The significance of this reaction was 
demonstrated by its application to the total synthesis of some useful natural products, 
such as seco-antofine (21a), (±)-septicine (21b), (±)-antofine (22a) and 
(±)-tylophoring (22b) (Scheme 10).  
Starting from the alkyne-tethered hydroxamic acid esters 17a and 17b, the 
intramolecular oxidative annulation reaction occurred in very high yields, producing 
18a and 18b in 94% and 97% yields, respectively. Followed by a standard 
intramolecular Mitsunobu reaction,
[13]
 indolizidine compounds 19a and 19b were 
formed. Then the TMS group was removed by TBAF, affording 20a and 20b in 82% 
and 86% yields, respectively. Under Moore’s conditions,[14] 20a and 20b changed into 
seco-antofine (21a) and (±)-septicine (21b), in 72% and 81% yields. In the end, the 
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target molecules (±)-antofine (22a) and (±)-tylophorine (22b) were synthesized by an 
oxidative coupling reaction under the Liepa conditions
[15]
 in moderate yields, 65% 
and 77%, respectively (Scheme 10). 
 
Scheme 10 Total synthesis of some useful natural products  
 
 
Very recently Cramer and coworkers reported a rhodium(III)-catalyzed synthetic 
route towards benzosultams (24a-c in Scheme 11) from N-acyl sulfonamides with 
alkynes using CuOAc/O2 as external oxidant. Under standard conditions, both ortho- 
and meta-substituted sulfonamides reacted well with alkynes to give corresponding 
substituted sultams in good yields. The new method showed good compatibility to 
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some N-acyl heteroaryl sulfonamides, e.g., 24c was obtained in an excellent yield 
(99%). Unsymmetrical alkynes gave moderate to good regioselectivities, which was 
somewhat dependent upon the alkynes concentrations.
[16]
 
 
Scheme 11 Synthesis of sultams by a rhodium-catalyzed annulation reaction 
 
 
 
1.2 Rhodium-Catalyzed Addition Reactions 
 
Transition metal-catalyzed addition of ortho-C-H bond to some unsaturated 
carbon-carbon or carbon-hetero bonds constitute one of the most efficient and 
economical methods in the field of organic synthesis. The transformation has a great 
potential for the synthesis of ortho-alkylated compounds from simple starting 
materials via five membered intermediates. Herein, the transformations have attracted 
great attention and been well documented. Notably, alkylation reactions with new 
carbon-carbon bonds constructed by direct C-H activations are of great importance 
and highly desirable. Generally, the regioselective ortho-oriented C-H activations can 
be achieved by the coordination between metal complexes and the specific atoms on 
the directing groups. In this regard, various directing groups have been exploited for 
the transformations, resulting in mono- or di-alkylated products. In this part, we will 
introduce some rhodium-mediated ortho-C-H activations and subsequent addition 
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reactions. 
With a catalytic amount of Cp*Rh(C2H3SiMe3)2, acetophenones reacted well with 
trimethylvinylsilanes, forming anti-Markovnikov products in good selectivity under 
mild conditions (80 
o
C, Scheme 12). As proposed, the methodology gave good 
selectivity owing to the coordination between the rhodium complex and the oxygen 
atom of the ketone group.
[17]
 
 
Scheme 12 Rhodium-catalyzed ortho-alkylation of ketones and mechanism cycle 
 
 
 
With 3-methyl pyridinyl group utilized as the directing group, 2-phenyl-3-methyl 
pyridines reacted well with olefins, affording ortho-substituted products in good 
yields (Scheme 13).
[18]
 In this case, the 3-methyl pyridinyl group was utilized to avoid 
the bis-alkylated byproducts. In addition, a ligand was required for restraint 
coordination between the rhodium complex and substrates.
[19]
 Notably, the cone angle 
of the ligands affected the yields significantly, from 92% to 21% (Scheme 13). 
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Scheme 13 Rhodium-catalyzed alkylation of phenyl pyridines 
 
 
 
In a similar manner, the same authors extended the conditions to pyridinyl alkenyl 
compounds with the assistance of a Rh(I) catalyst.
[20]
 For example, 2-isopropenyl 
pyridine (30) reacted smoothly with 1-hexene (26d), forming the β-alkylated products 
31 and 32 as a mixture with a 2:1 E/Z isomeric ratio (Scheme 14). 
 
Scheme 14 Rh(I)-catalyzed β-alkylation reaction of pyridinyl alkenyl compounds 
 
 
 
Some other nitrogen atom-containing functional groups, such as aromatic 
ketimines or aldimines, can also be used as the directing groups for the 
rhodium-catalyzed addition reactions. Thus, Jun and coworkers developed a 
chelation-assisted Rh(I)-catalyzed ortho-alkylation reaction of aromatic ketimines 
with olefins (Scheme 15). As proposed, the catalytic cycle initiated with the oxidative 
addition of the ortho-C-H bond to the electron-rich [RhCl(PPh3)3], followed by olefin 
coordination and hydride insertion. Then, the ortho-alkylated ketone was formed by 
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reductive elimination and successive hydrolysis (Scheme 54).
[21]
 
 
Scheme 15 Imine-directed addition reaction towards ortho-alkylated ketones 
 
 
 
The reaction was then extended to aromatic ketimines with active alkenes, giving 
ortho-alkylated ketones in the same manner.
[22]
 Various functional groups on the 
alkenes were well tolerated in the system. For example, methyl acrylate (26f), 
N,N-dimethyl acrylamide (26g), phenyl vinyl sulfone (26h) and acrylonitrile (26i) 
reacted with ketimine 33b successfully, giving the desired products in acceptable to 
good yields (34c-f in Scheme 16). 
 
Scheme 16 Rhodium-catalyzed ketimine-directed addition for alkylated ketones 
 
 
 
Very recently, Bergman and Ellman reported a rhodium-catalyzed alkylation 
reaction of ,-unsaturated aldimines. The intermolecular reaction of ,-unsaturated 
aldimines led to ,-unsaturated aldehydes in excellent yields. For example, 
N-(2-methylallylidene)-butanamine (35) reacted with 1-hexene (26d) successfully, 
affording the desired products 36 and 37 in a combined 100% yield with an E:Z 
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isomeric ratio of 95:5 after hydrolysis (Scheme 17).
[23]
 
 
Scheme 17 Rhodium-catalyzed alkylation of ,-unsaturated aldimines 
 
 
 
In a similar way, aromatic aldimines with tethered alkenes meta to the imine group 
(38a-c) underwent an intramolecular C-H addition reaction, affording the desired 
products in good yields (Scheme 18). The formation of linear or branched addition 
products depended on the alkene tether.
[24]
 
 
Scheme 18 Rh-mediated intramolecular C-H addition reaction 
 
 
 
Similarly, Ellman and Bergman reported an intramolecular addition reaction of 
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N-alkenyl benzimidazole 41 in the presence of [RhCl(coe)2]2 and PCy3, yielding the 
desired products 42 in moderate to good yields (Scheme 19). As proposed, the 
reaction proceeded via intermediates A, B and C. 
1
H-NMR spectra confirmed the 
existence of the intermediates. To get a better understanding of the mechanism, an 
isotopic labeling experiment was carried out, affording a d2-product 44-d2 as shown in 
the Scheme 19.
[25]
 
 
Scheme 19 Intramolecular addition reaction of N-alkenyl benzimidazoles 
 
 
 
A more challenging asymmetric synthesis of some ortho-chained products was 
disclosed by Murai and coworkers. For example, N-methyl-2-octa-1,5-dienyl-1H-imi- 
-dazole (45) underwent the reaction smoothly, by aid of [RhCl2(cyclooctene)2]2 and a 
ferrocenylphosphine ligand (L
* 
in Scheme 20), giving the annulated product 46 in 
75% yield with 82% ee. The N-methyl imidazole group was deduced to play a key 
role as the directing group with coordination to the rhodium complex. Interestingly, 
the pyridinyl group was also compatible as a new directing group. Finally, chiral 
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cyclo-aliphatic ketones 48 were produced by a ruthenium-mediated oxidative 
cleavage reaction (Scheme 20).
[26]
 
 
Scheme 20 Intramolecular asymmetric addition reaction 
 
 
 
Recently, Li and coworkers documented an efficient Rh(III)-catalyzed 2-phenyl 
pyridine-assisted C-H activation and subsequent conjugative addition reaction. Under 
the mild conditions, phenyl pyridines 49 reacted with 2-cyclohexenone (50), 
providing mono-alkylated products 51 in good to excellent yields (57% - 98%). 
Interestingly, 4-acetyl phenyl pyridine reacted with 2-cyclohexenone (50), affording 
the di-alkylated product 52 in a quantitative yield (Scheme 21).
[27]
  
 
 
 
 
 
 
 
 
 
Chapter 1 
18 
 
Scheme 21 Rh(III)-catalyzed addition reaction of 2-phenyl pyridines and 
2-cyclohexenone 
 
 
 
α,β-Unsaturated ketones such as chalcones were able to react with 2-aryl pyridines, 
presented by Huang and coworkers, affording conjugative addition products under 
mild conditions (60 
o
C, Scheme 22). As proposed, the reaction proceeded by the 
coordination of the chalcone and the rhodium complex, which produced arylrhodium 
complex A. Subsequent conjugative addition afforded rhodium enolate B or 
(oxa--allyl) rhodium species C, which provided the desired product after protonation 
by the aid of acetic acid (Scheme 22).
[28]
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Scheme 22 Rh(III)-catalyzed addition reaction of aryl pyridines and chalcones 
 
  
 
2 General Introduction of Sulfoximines and Metal-catalyzed 
Synthesis of N-Substituted Sulfoximines 
 
2.1 General Introduction of Sulfoximines 
 
Sulfoximines, the stable monoaza analogues of sulfones, have a distorted 
tetrahedral structure with some distinguishing features: 1) IR spectra could provide 
evidence for the existence of the S=N and S=O double bonds in sulfoximines; 2) The 
nitrogen atom linked to the sulfur (R
1 ≠ CH2R
2
) is nucleophilic; 3) The hydrogens of 
the alkyl group on the -position of the sulfur atom are acidic, and the acidity is 
largely affected by the R
3
 group on the nitrogen atom. For example, the pKa is 32 
when R
3 
= Me, while the pKa is 23 when R
3 
= Ts (Figure 1). 
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Figure 1 Key structures for sulfones and sulfoximines 
 
 
 
Consequently, sulfoximine derivatives have attracted a great attention not only for 
biomedical and pharmaceutical chemistry, but also for applications as chiral ligands 
and building blocks for pseudopeptides. For example, (2S,5S)-methionine sulfoximine 
(compound 56 in Scheme 23) was recognized as the toxic factor for canine hysteria 
while buthionine sulfoximine (compound 57 in Scheme 23) has specific inhibitory 
effects on γ-glutamylcysteine synthetase. Various sulfoximines (e.g., 58, 59 in 
Scheme 23) have been proved to be applicable as chiral ligands in metal-catalyzed 
asymmetric Diels-Alder, hetero-Diels-Alder, allylic alkylation and Mukaiyama-type 
aldol reactions.
[29]
  
 
Scheme 25 Some sulfoximine-cored compounds 
 
 
 
Chapter 1 
21 
 
N-Substituted sulfoximines are of great significance for various properties with 
different functional groups on the nitrogen atom. In this part, we will introduce some 
important approaches towards N-substituted sulfoximines by transition 
metal-catalyzed reactions. 
 
2.2 Synthesis of N-Substituted Sulfoximines by Metal-Catalysis 
 
Transition metal-catalyzed C-H or N-H activations and subsequent 
functionalization protocols of NH-sulfoximines are highly useful and interesting 
topics in organic synthesis. The construction of different C-C and C-N bonds on the 
NH-sulfoximines is extremely difficult by traditional organic synthesis. In this context, 
Bolm and Harmata have reported various valuable new C-C and C-N bonds formation 
methodologies from NH-sulfoximines with assistance of transition metal catalysts. 
In 2000, Bolm and coworkers described a direct approach towards N-aryl 
sulfoximines by using a palladium-catalyzed cross-coupling reaction. In the presence 
of Pd(OAc)2 and tol-BINAP, NH-sulfoximines reacted with halo arenes, affording 
N-aryl sulfoximines in acceptable to excellent yields (Scheme 24).
[30]
 Interestingly, 
aryl bromides showed the best activity, giving the desired products in nearly 
quantitative yields. Lithium or silver salts were required when aryl iodides were 
applied as coupling partners.  
As proposed by the authors, the catalytic cycle initiated with reduction of Pd(II) 
into Pd(0) species A (Scheme 24). Then oxidative addition of complex A into the 
aryl-bromide bond took place, forming C-Pd-Br species B. Followed by the 
coordination of the NH-sulfoximine to the palladium complex B, HBr was released in 
the presence of base, forming aryl-palladium-sulfoximide intermediate D, which was 
easily transformed into the product with a reductive elimination step (Scheme 24). 
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Scheme 24 Palladium-catalyzed N-arylation of NH-sulfoximines and proposed 
mechanism 
 
 
 
In a similar manner, N-vinyl sulfoximines were obtained in excellent yields by a 
palladium-catalyzed intermolecular coupling reaction of NH-sulfoximines with vinyl 
bromides. Interestingly, vinyl triflate 65 also effectively coupled with 
NH-sulfoximines, giving the desired products in nearly quantitative yields (66a and 
66b in Scheme 25).[31] 
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Scheme 25 Palladium-catalyzed N-vinylation of NH-sulfoximines 
 
 
 
Based on the previous results of the palladium-catalyzed approaches for N-aryl or 
N-vinyl sulfoximines, Harmata disclosed a one-pot reaction for the synthesis of 
various 1,2-benzothiazines from NH-sulfoximines and o-halobenzaldehyde under 
Buchwald-Hartwig conditions (Scheme 26).
[32] 
The simple protocol gave rise to 
1,2-benzothiazines in a one-pot manner. 
 
Scheme 26 Synthesis of 1,2-benzothiazines under Buchwald-Hartwig conditions 
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To make a complement to the palladium-catalyzed methodologies, Cho and Bolm 
developed a high-yielding protocol for N-aryl sulfoximines with less expensive CuI as 
catalyst. The novel ligand-free protocol showed good compatibility with various 
substituted aryl iodides and substituted NH-sulfoximines (Scheme 27).
[33]
 
 
Scheme 27 Cu(I)-catalyzed N-arylation of NH-sulfoximines 
 
 
 
Organoboron reagents have attracted great attention due to the advantages of air 
and moisture stability, low toxicity, and availability. In addition, organoboronic acid 
possibly enhances electron density at the boron center in the presence of base and thus 
facilitates the transmetallation with a metal catalyst under mild conditions. In this 
context, several examples of metal-catalyzed coupling of organoboron reagents with 
aryl or alkyl-XH (X = O, S, and N) have been reported. Among those contributions, 
Bolm and coworkers developed a convenient method for the N-arylation sulfoximines. 
NH-Sulfoximines reacted with aryl boronic acids in the presence of a catalytic amount 
of the Cu(OAc)2 (10 mmol%) in MeOH at room temperature, yielding the desired 
products in moderate to good yields (Scheme 30).
[34]
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Scheme 28 Copper(II)-mediated N-arylation of NH-sulfoximines with boronic 
acids 
 
 
 
Diaryliodonium salts also can be utilized as the arylation reagents. To this end, an 
ultrasound-assisted approach towards N-aryl sulfoximines was described by Vaddula 
and Varma. The reaction proceeded in aqueous polyethylene glycol-400 with a 
catalytic amount of cuprous bromide at room temperature, affording the desired 
N-aryl sulfoximines in high yields (Scheme 29).
[35]
 
 
Scheme 29 Ultrasound-assisted N-arylation of NH-sulfoximines 
 
 
 
The above methodologies towards N-aryl sulfoximines required prefunctionlized 
substrates or harsh reaction conditions. In this context, Bolm and Miura reported an 
attractive copper-catalyzed direct dehydrogenative C-N coupling of heteroarenes with 
NH-sulfoximines, affording N-heteroaryl sulfoximines in good yields. Notably, the 
enantiopure N-heteroaryl sulfoximines were easily obtained under the standard 
conditions (Scheme 30).
[36]
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Scheme 30 Synthesis of N-arylated sulfoximines by hetero-dehydrogenative coupling 
reaction 
 
 
 
Recently, Bolm and coworkers introduced a high-yielding dehydrogenative 
cross-coupling method for the synthesis of previously unknown N-alkynylated 
sulfoximines from NH-sulfoximines with terminal alkynes. This unprecedented 
protocol utilized a copper(II) salt as catalyst and oxygen as oxidant, involving a dual 
C-H/N-H activation procedure (Scheme 31).
[37]
 
 
Scheme 31 Copper-catalyzed N-alkynation of NH-sulfoximines 
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Later, the same authors developed a copper-catalyzed dehydrogenative cross 
coupling protocol towards N-acyl sulfoximines with low catalyst loadings (1 mol%). 
With easily commercial available aldehydes as coupling partners, the representative 
transformation was easily realized by dual C-H/N-H functionalization procedures 
with tert-butyl hydroperoxide (TBHP) as oxidant, affording the desired products in 
good to high yields (Scheme 32).
[38]
 
 
Scheme 32 Cu(I)-catalyzed N-acylation of NH-sulfoximines 
 
 
 
Very recently, Parthasarathy and Bolm repoted a Rh(III)-catalyzed alkenylation 
method from N-acyl and N-aroyl sulfoximines by a direct ortho-C-H bond activation 
procedure (Scheme 33). AgSbF6 was deduced to play a key role in facilitating the 
reaction by removing the chloride from the [RhCp*Cl2]2 complex, generating a more 
active cationic rhodium species.
[39]
 
 
Scheme 33 Rh(III)-catalyzed alkenylation of sulfoximines 
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Part II Rhodium-catalyzed Annulation Reaction of Sulfoximines 
and Alkynes 
 
1 Research Objective 
 
Previously, N-H or C-H functionalization transformations of NH-sulfoximines 
have been extensively studied and documented. However, there are no reports on the 
synthesis of 1,2-benzothiazines from NH-sulfoximines by dual C-H/N-H activation 
procedures. 1,2-Benzothiazines have attracted significant attention due to their 
usefulness as scaffolds or as synthetic intermediates in pharmaceutical development. 
Approaches towards 1,2-benzothiazines by annulation reactions of either alkynes or 
alkenes with sulfonimidoyl chlorides,
 
or by a domino sequence involving a 
Buchwald-Hartwig protocol
 
followed by ring formation are well established.
[40] 
In the 
context, Harmata and coworkers reported an new approach to 1,2-benzothiazines and 
benzoisothiazoles by Sonogashira coupling of S-2-bromophenyl-S-methyl 
NH-sulfoximines with terminal alkynes (Scheme 34, eq. A).
[41]
 However, most of the 
documented methodologies required toxic halogenated starting materials or harsh 
reaction conditions, including a low temperature (-78 
o
C) and strong base (n-BuLi). 
In this part we will describe a new approach towards 1,2-benzothiazines from 
NH-sulfoximines with alkynes by a Rh(III)-catalyzed C-H/N-H activations strategy. 
The C-H/N-H activations and subsequent annulations proceed in the presence of a 
rhodium catalyst (Scheme 34, eq. B). 
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Scheme 34 Research Objective 
 
 
 
2 Results and Discussions 
 
2.1 Optimization of Annulation Reaction of Sulfoximines with 
Alkynes  
 
2.1.1 Screening of Transition Metal Catalysts 
 
To find suitable reaction conditions, sulfoximine 61a and diphenylacetylene (2a) 
were used as model starting materials. The effect of rhodium complexes and oxidants 
were also examined (see Table 1).  
Rhodium complex [Cp*Rh(MeCN)3][BF4]2 was the most effective complex at 
forming 76a, in 89% yield (Table 1, entry 1). Other rhodium complexes such as 
[RhCp*Cl2]2, [Rh(OAc)2]2, [RhCl(COD)]2 and Rh(PPh3)3Cl, were less reactive (Table 
1, entries 2-3) or completely inactive (entries 4-5). Palladium(II) complexes, such as 
PdCl2(CH3CN)2, PdCl2(PhCN)2, PdCl2(PPh3)2 and Pd(OAc)2 were ineffective for the 
reaction (entries 6-9). Fe(OAc)2 was a much more efficient additive (entry 1) than 
Fe(acac)3, Fe(OTf)3, or Cu(OAc)2 (entries 10-12). Other additives such as PhI(OAc)2 
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and K2S2O8 were totally inactive (entries 13, 14). Notably, no reaction took place 
when the reaction was carried out in the absence of the metal catalyst and additive 
(entry 15). 
 
Table 1 Screening of transition metal catalysts 
 
 
 
Entry Catalyst Additive Yield [%] 
1 [Cp*Rh(MeCN)3][BF4]2 Fe(OAc)2 89 
2 [RhCp*Cl2]2 Fe(OAc)2 35 
3 [Rh(OAc)2]2 Fe(OAc)2 trace 
4 [RhCl(COD)]2 Fe(OAc)2 0 
5 Rh(PPh3)3Cl Fe(OAc)2 0 
6 PdCl2(CH3CN)2 Fe(OAc)2 0 
7 PdCl2(PhCN)2 Fe(OAc)2 0 
8 PdCl2(PPh3)2 Fe(OAc)2 0 
9 Pd(OAc)2 Fe(OAc)2 0 
10 [Cp*Rh(MeCN)3][BF4]2 Fe(acac)3 trace 
11 [Cp*Rh(MeCN)3][BF4]2 Fe(OTf)3 trace 
12 [Cp*Rh(MeCN)3][BF4]2 Cu(OAc)2 38 
13 [Cp*Rh(MeCN)3][BF4]2 PhI(OAc)2 0 
14 [Cp*Rh(MeCN)3][BF4]2 K2S2O8 0 
15 - - 0 
Notes: [a] Unless otherwise mentioned, all reactions were carried out 
using sulfoximine 61a (0.30 mmol), alkyne 2a (0.36 mmol), catalyst (5.0 
mol %), additive (20 mol %) and toluene (2.5 mL) under O2 (1 atm) at 
100 
o
C for 48 h. 
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2.1.2 Effect of Solvents 
 
The effect of solvents was also important to the catalytic reaction (Table 2). 
Toluene was found to be the optimal solvent, affording 76a in 89% yield (entry 1). 
Other solvents such as tert-amyl alcohol, acetonitrile and DCE (1,2-dichloroenthane) 
were less effective for the catalytic reaction giving 76a in 79%, 56% and 58% yields, 
respectively (entries 2-4). DMF (dimethylformamide) and DMSO (dimethyl sulfoxide) 
were totally ineffective (entries 5, 6). 
 
Table 2 Screening of solvents 
 
 
 
Entry Solvent Yield(%) 
1 toluene 89 
2 tert-amyl alcohol 79 
3 CH3CN 56 
4 DCE 58 
5 DMF 0 
6 DMSO 0 
Note: [a] Conditions: sulfoximine 61a (0.30 mmol), alkyne 2a (0.36 
mmol), [Cp*Rh(MeCN)3][BF4]2 (5.0 mol %), Fe(OAc)2 (20 mol %), O2 
(1 atm), solvent (2.5 mL), 100 °C , 48 h. 
 
 
 
Chapter 1 
32 
 
2.2 Substrate Scope 
 
Table 3 Substrate scope 
 
 
Entry 61 2 76 R
1
 Yield (%) 
1 61a 2a 
 
76a: R
1
 = H 89 
2 61b 2a 76b: R
1
 = 3-Me 88
[b]
 
3 61c 2a 76c: R
1
 = 4-MeO 86 
4 61d 2a 76d: R
1
 = 4-NO2 72 
5 61e 2a 76e: R
1
 = 4-Cl 79 
6 61f 2a  76f: R
1
 = 4-Br 81 
7 61h 2a 
 
76g 85 
8 61a 2b 
 
76h: R
3
, R
4
 = 
4-MeOC6H4 
93 
9 61a 2c 
76i: R
3
, R
4
 = 
4-FC6H4 
78 
10 61a 2d 
76j: R
3
, R
4
 = 
4-ClC6H4 
86 
11 61a 2e 
76k: R
3
,R
4
 = 
2-Thienyl 
87 
12 61a 2f 
76l: R
3
,R
4
 = 
Et 
67 
13 61a 2g 
76m: R
3
,R
4
 = 
n-Pr 
72 
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14 61a 2h 
76n: R
3
 = Me, R
4
 =  
Ph 
76n’: R3 = Me, R4 =  
Ph 
85 (85:15)
c
 
15 61a 2i 
76o: R
3
 = COOMe, 
R
4
 = Ph 
76o’: R3 = COOMe, 
R
4
 = Ph 
82  
(76o’ not 
observed)
d
 
16 61a 2j 
76p: R
3
 = Ph, R
4
 =  
4-MeOC6H4 
76p’: R3 = Ph, R4 = 
4-MeOC6H4 
90 (50:50)
c
 
17 61a 2k 
76q: R
3
 = Ph, R
4
 =  
4-NO2C6H4 
76q’: R3 = Ph, R4 = 
4-NO2C6H4 
80 (95:5)
c
 
18 61a 2l 
76r: R
3
 = Ph, R
4
  
2-Naphthyl 
76r’: R3 = Ph, R4 = 
2-Naphthyl 
78 (50:50)
c
 
Notes: [a] Conditions: sulfoximine 61 (0.30 mmol), alkyne 2 (0.36 mmol), 
[Cp*Rh(MeCN)3][BF4]2 (5.0 mol %), Fe(OAc)2 (20 mol %), toluene (2.5 
mL), O2 (1 atm), 100 °C , 48 h. [b] Ratio of 76b:76b’ = 90:10, determined by 
NMR. [c] Ratio determined by NMR. [d] Structure comfirmed with 
COSY-NMR. 
 
To evaluate the substrate scope of the reaction, several substituted 
NH-sulfoximines (61b-g) were reacted with diphenylacetylene (2a) under the 
optimized reaction conditions. In general, all transformations proceeded well, 
affording the corresponding 1,2-benzothiazines in yields ranging from 72-89% (Table 
3, entries 1-7). The reaction of meta-substituted NH-sulfoximine 76b revealed a 
regioselective favor for a less hindered C-H activation pathway, leading to the two 
expected regioisomers (76b and 76b’) in a combined 88% yield with an isomeric ratio 
of 90:10 (entry 2). Reactions with para-substituted NH-sulfoximines 61c-f showed 
that the influence of electronic effects induced by methoxy, nitro, and halo groups 
were minor and both chloro and bromo substituents were well tolerated (Table 3, 
entries 3-6). If an S-phenyl group (as in 61h) was utilized instead of an S-methyl 
substituent (as in 61a-f), the yield of the resulting 1,2-benzothiazine (76g) remained 
essentially unaffected (85%, Table 3, entry 7). Pleasingly, other alkynes also reacted 
well (as determined by the reactions with 61a as the coupling partner). In the series of 
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symmetrically substituted diphenylacetylenes, the 4,4’-dimethoxy-, 4,4’-difluoro-, 
and 4,4’-dichloro derivatives were tested, and all gave the corresponding products 
(76h-j) in high yields (up to 93%, Table 3, entries 8-10). Starting from 
di(2-thienyl)acetylene (2e), 1,2-benzothiazine 76k was obtained in 87% yield (Table 3, 
entry 11). When aliphatic alkynes were applied, the yields were slightly lower as 
indicated by conversions of hex-3-yne (2f) and oct-4-yne (2g), providing 
1,2-benzothiazines 76l and76m in 67% and 72% yields, respectively (Table 3, entries 
12 and 13). 
Reactions of NH-sulfoximine 61a with unsymmetrically substituted alkynes were 
expected to lead to regioisomeric products. Depending on the substitution pattern, the 
regioselectivity was either high (up to >95:5) or nil (Table 3, entries 14-18). Thus, 
1-phenyl-1-propyne (2h) and phenyl propiolate (2i) underwent the oxidative 
annulation reaction effectively, leading to the two regioisomeric products (76n/76n' 
and 76o/76o’) in high yields with isomeric ratios of 85:15 and >95:5, respectively 
(Table 3, entries 14 and 15). The chemical identity of 76n was unequivocally 
established by X-ray single crystal structure analysis (Figure 4). In contrast, no 
regioselectivity was observed from unsymmetrical diarylacetylenes 2j, 2k, and 2l, 
which gave the corresponding regioisomeric pairs 76p/76p’, 76q/76q’, and 76r/76r’ 
in equal amounts (Table 3, entries 16-18). The yields were 90%, 80%, and 78% 
respectively. 
 
Figure 4 ORTEP diagram and X-ray data of 76n (CCDC No. 937990) 
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2.3 Mechanistic Investigation 
 
Based on the earlier work, a reasonable mechanism for the presented reaction can 
be deduced, as illustrated in Scheme 37. Most likely, the catalytic cycle initiated with 
an acetate transfer from Fe(OAc)2 to [Cp*Rh(MeCN)3][BF4]2. Then, the resulting 
rhodium species Cp*Rh(OAc)2 reacted with the NH-sulfoximine 61a, affording 
five-membered rhodacycle II with a loss of acetic acid and subsequent ortho-C-H 
bond activation. Subsequently, coordinative insertion of alkyne 2a into the 
rhodium-carbon bond of intermediate II gave a seven-membered rhodacycle IV. Then, 
reductive elimination of rhodacycle IV afforded the 1,2-benzothiazine and a Rh(I) 
species, which was reoxidized by oxygen combined with the iron salt, regenerating 
the active Rh(III) species for the next catalytic cycle (Scheme 37). 
 
Scheme 37 Proposed mechanism for the annulation reaction 
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In order to support the proposed mechanism, we tried to isolate the key 
intermediate II (Scheme 37). Thus, heating of 61a in the presence of 
[Cp*Rh(MeCN)3][BF4]2 (1 equivalent) in toluene at 100 °C for 16 h led to the 
five-membered rhodacycle II with one molecule of probably coordinated compound 
61a. This complex was characterized by 
1
H, 
13
C NMR, IR and mass spectrum. 
However, several attempts to crystallize intermediate II from various co-solvents 
failed. Finally, we found that when intermediate II was treated with NaI in MeOH at 
room temperature for 30 min, a rhodium intermediate II’ was formed that could be 
isolated (Scheme 38). The structure was elucidated by single crystal X-ray diffraction 
(Figure 5). The reaction of rhodacycle II (X = BF4
-
) with 2a and Fe(OAc)2 in toluene 
at 100 °C for 2 h afforded 76a, whereas the reaction of rhodium intermediate II’ (X = 
I) required 15 h to give 76a in 78% yield.
 
 
Scheme 38 Intermediates isolation and test of activities 
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Figure 5 ORTEP diagram of rhodacyle II’ (CCDC No. 949306) 
 
 
 
To get further mechanistic insight, an intramolecular kinetic isotopic effect (KIE) 
experiment was carried out (eq. 3). For this study, a deuterated sulfoximine (61a-d1) 
was prepared and employed. An intramolecular competition experiment of 76a-d1 
with 2a showed a kH/kD constant of 2.22 (Scheme 39). The KIE result indicated that a 
direct C-H bond cleavage was involved. 
 
Scheme 39 KIE research 
 
 
 
2.4 Oxidative Cleavages of 1,2-Benzothiazines 
 
A selective oxidative transformations of 1,2-benzothiazines were demonstrated in 
Scheme 40. Thus, treatment of 76a with m-CPBA (meta-chloroperoxybenzoic acid) in 
DCM (dichloromethane) at 0 °C to r.t. for 8 h gave a clean conversion of 
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ortho-acyl-N-acyl sulfoximine 77a in 96% yield. In a similar fashion, 
1,2-benzothiazines 76d and 76f were easily converted into 77b and 77c in high yields, 
without affecting any other functional groups.  
 
Scheme 40 Clevages of 1,2-benzothiazines 
 
 
 
3 Summary  
 
In summary, we developed a rhodium-catalyzed process for the synthesis of 
1,2-benzothiazines from NH-sulfoximines and alkynes. The combination of simple 
Fe(OAc)2 (20 mol %) and O2 (1 atm) allows the metal reoxidation, closing the 
catalytic cycle. Mechanistically, the transformation involvea a dual C-H/N-H 
activation, which was substantiated by KIE studies and the isolation of a reactive 
rhodacycle intermediate. The method is high-yielding and suitable for the synthesis of 
libraries of functionalized 1,2-benzothiazines. 
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4 Experimental Part 
 
4.1 General Information 
 
All reaction mixtures were analyzed by thin layer chromatography using 
aluminum foil backed silica TLC plates with a fluorescent indicator from Merck. 
UV-Active compounds were detected with a UV lamp (λ = 254 nm). For flash column 
chromatography, silica gel was used as stationary phase. 
1
H and 
13
C NMR spectrum 
were recorded either on a Varian V-NMRS 600, Varian V-NMRS 400 or Varian 
Mercury 300 in deuterated chloroform at 25 °C. Chemical shifts () were reported in 
ppm, and spin-spin coupling constants (J) were given in Hz, while multiplicities were 
abbreviated by br s (broad singlet), s (singlet), d (doublet), t (triplet), q (quartet) and 
m (multiplet). High resolution mass spectra (HRMS) was recorded on a Finnigan 
MAT 95 spectrometer.  
All solvents were dried according to known methods and distilled before use. 
Substituted NH-sulfoximines and alkynes were synthesized according to literature 
procedures. All other reagents were purchased from Sigma-Aldrich, Acros or Alfa 
Aesar and used without further purification. 
 
4.2 General Procedure for the Synthesis of 1,2-Benzothioazines 
 
A Schlenk tube (60 mL) equipped with a stirring bar was loaded with the 
NH-sulfoximine (0.5 mmol), alkyne (0.6 mmol), [Cp*Rh(MeCN)3][BF4]2 (13.5 mg, 
0.025 mmol, 5 mol %) and Fe(OAc)2 (18 mg, 0.1 mmol, 20 mol %). Under an oxygen 
atmosphere (1 atm), dry toluene (3.0 mL) was added, and the reaction mixture was 
allowed to stir at 100 °C for 48 h. After cooling to room temperature, the mixture was 
filtered through a short celite pad and washed with dichloromethane (3 × 20 mL). The 
filtrate was concentrated, and the product was purified by flash column 
chromatography using silica gel with a mixture of hexane and ethyl acetate as eluent. 
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4.3 Synthesis of Sulfoximine 60a-d1 
 
 
2-Bromothioanisole (2.03 g, 10 mmol) was dissolved in dry THF (20 mL). The 
solution was cooled to -78 
o
C, and n-BuLi (6.25 mL, 1.6 M, 10 mmol) was added 
dropwise. After stirring for 1 h at -78 
o
C, D2O (4.0 mL) was added dropwise and 
stirring was continued while the Dewar flask was removed 10 min after the addition. 
The mixture was allowed to stir for an additional 4 h at room temperature. Then H2O 
(20 mL) was added, the phases were separated, and the aqueous layer was extracted 
with DCM (3 × 20 mL). The combined organic layers were dried over anhydrous 
MgSO4, filtered, concentrated, and the oily crude product was purified by distillation 
under reduced pressure (42-43 
o
C, 2 mm Hg) to give a colorless oil in 72% yield. 
The subsequent two steps (oxidation of the sulfide to the sulfoxide and subsequent 
imination of the sulfoxide to the sulfoximine) were carried out according to the 
literature procedures.
[42]
 
 
4.4 Intramolecular Kinetic Isotope Effect (KIE) 
 
A Schlenk tube (60 mL) with a stirring bar was loaded with the sulfoximine 
61a-d1 (65.5 mg, 0.3 mmol), 2a (64.1 mg, 0.36 mmol), Cp*Rh(MeCN)3(BF4)2 (8.0  
mg, 5 mol %) and Fe(OAc)2 (11 mg, 20 mol %). Under an oxygen atmosphere (1 atm), 
dry toluene (2.0 mL) was added, and the reaction mixture was allowed to stir at 
100 °C for 48 h. After cooling to room temperature, the mixture was filtered through a 
short celite pad and washed with dichloromethane (3 × 20 mL). The filtrate was 
concentrated, and the product was purified by flash column chromatography using 
silica gel with a mixture of hexane and ethyl acetate as eluent to give a mixture of 
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products 76a and 76a-d1 in 56% yield. The ratio of the two products was determined 
by 
1
H NMR integration method to give intramolecular kinetic isotopic effect (KIE) 
constant as KH/KD = 2.22. 
 
4.5 Synthesis of Rhodacycles II and II’ 
 
A Schlenk tube (25 mL) with a stirring bar was loaded with sulfoximine 61a (46.6 
mg, 0.3 mmol) and [Cp*Rh(MeCN)3][BF4]2 (160.8 mg, 0.3 mmol). Under an argon 
atmosphere, dry toluene (5.0 mL) was added, and the reaction mixture was allowed to 
stir at 100 °C for 16 h, and then cooled to room temperature. The mixture was filtered 
through a short celite pad and washed with dichloromethane (3 × 10 mL) and MeOH 
(3 × 10 mL). The filtrate was concentrated by vacuum and the product was purified by 
preparative ALOX TLC (elute: EtOAc/hexane = 1:1) to afford the crude rhodium 
complex II as light yellow solid. The crude complex was characterized by 
1
H, 
13
C 
NMR, IR and mass spectrum. Then, crude II’ was treated with NaI in MeOH at room 
temperature for 30 min. After the remove of the solvent, the pure rhodium 
intermediate II’ was purified with a neutral Al2O3 column in 72% yield from the 
NH-sulfoximine. Single crystal of II’ was obtained from a MeOH solution, and the 
structure in the solid state was determined by X-ray diffraction. 
 
4.6 Reactions of Rhodacycles II and II’ with Alkyne 2a 
 
A Schlenk tube (25 mL) with a stirring bar was loaded with rhodium complex II 
(30 mg, 0.06 mmol), alkyne 2a (10.6 mg, 0.06 mmol) and Fe(OAc)2 (2.4 mg, 0.01 
mmol). Under an oxygen atmosphere (1 atm), dry toluene (1.0 mL) was added, and 
the reaction mixture was allowed to stir at 100 °C for 2 h. The mixture was filtered 
through a short celite pad and washed with dichloromethane (3 × 10 mL). The filtrate 
was concentrated, and the product was purified by flash column chromatography 
using silica gel with a mixture of hexane and ethyl acetate as eluent to afford 76a. 
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With an analogous experimental procedure, the rhodium complex II’ reacted with 
alkyne 2a, giving 76a in 78% yield for 15 h. 
 
4.7 Oxidative Cleavages of 1,2-Benzothiazines 
 
1,2-Benzothiazine 76a (66.3 mg, 0.2 mmol) was dissolved in dry DCM (2 mL). 
The solution was cooled to 0 
o
C, and m-CPBA (75% with water, 92.0 mg, 0.4 mmol) 
in dry DCM (2 mL) was added slowly at 0 °C. The resulting mixture was allowed to 
stir at the room temperature for 8 h. Then, the mixture was washed with a saturated 
solution of NaHCO3, and the combined organic layers were washed with brine, dried 
over MgSO4 and concentrated. The product was purified by silica gel column 
chromatography to give 76a in 96% yield. In a similar fashion, 1,2-benzothiazines 
76d and 76f were converted into 77b and 77c in 82% and 90% yields, respectively. 
 
5 Data and Characterization 
 
1-Methyl-3,4-diphenyl benzothiazine 1-oxide (76a) 
 
Following the general procedure, 1,2-benzothiazine 76a was obtained as pale yellow 
solid in 89% yield (147.5 mg). A gradient of n-hexane/EtOAc: 5/1 was applied as 
eluent for the flash column chromatography purification. 
Melting point: 179-180 
o
C. 
1
H NMR (600 MHz, CDCl3)  = 7.81 (d, J = 7.9 Hz, 1H), 7.41- 7.37 (m, 2H), 7.22 – 
7.15 (m, 5H), 7.09 – 7.06 (m, 5H), 3.64 (s, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 146.0, 140.3, 137.7, 136.9, 132.4, 129.6, 128. 3, 
127.3, 126.7, 126.1, 123.3, 118.6, 112.8, 45.2 (ppm).  
MS (EI): m/z = 64.1 (39), 76.9 (100), 90.6 (26.7), 102.9 (99), 132.4 (63), 331.4 (M
+
, 
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2). 
IR (KBr):  = 3015, 2946, 2863, 1767, 1574, 1463, 1205, 967 (cm-1). 
HRMS (ESI): 332.1098, calcd. for [M+H
+
]: 332.1109. 
 
1,7-Dimethyl-3,4-diphenyl benzothiazine 1-oxide and 1,5-dimethyl-3,4-diphenyl 
benzothiazine 1-oxide (76b and 76b’)  
 
Following the general procedure, 1,2-benzothiazines 76b and 76b’ were obtained as 
pale yellow solid in a combined 88% yield (152.0 mg) with a isomeric ratio of 90:10, 
which was determined by 
1
H-NMR. A gradient of n-hexane/EtOAc: 5/1 was applied 
as eluent for the flash column chromatography purification. 
Melting point: 186-190 
o
C. 
1
H NMR (400 MHz, CDCl3)  = 7.72 (d, J = 7.2 Hz, 0.3H, minor), 7.64 (s, 3H, major), 
7.32 – 7.08 (m, 13H, major), 3.70 (s, 0.5H, minor), 3.66 (s, 3H, major), 2.54 (s, 0.5H, 
minor), 2.44 (s, 3H, major) (ppm).  
13
C NMR (101 MHz, CDCl3, major+minor)  = 144.8, 140.3, 137.9, 136.4, 134.6, 
133.8, 133.3, 132.4, 131.4, 130.7, 130.4, 129.6, 129.0, 128.9, 127.3, 127.1, 126.6, 
126.1, 122.7, 118.6, 112.7, 46.3, 45.2, 21.4, 21.2 (ppm).  
MS (EI): m/z = 104.2 (17), 181.8 (16), 224.4 (100), 226.5 (79), 344.1 (99), 345.7 (87), 
347.6 (M
+
, 6). 
IR (KBr):  = 3025, 2312, 2081, 1741, 1566, 1472, 1249, 974 (cm-1). 
HRMS (ESI): 346.1260, calcd. for [M+H
+
]: 346.1266. 
 
6-Methoxy-1-methyl-3,4-diphenyl benzothiazine 1-oxide (76c) 
 
Following the general procedure, 1,2-benzothiazine 76c was obtained as pale yellow 
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solid in 86% yield (155.4 mg). A gradient of n-hexane/EtOAc: 5/1 was applied as 
eluent for the flash column chromatography purification.  
Melting point: 196-197 
o
C. 
1
H NMR (400 MHz, CDCl3)  = 7.79 (d, J = 8.8 Hz, 1H), 7.31 – 7.05 (m, 10H), 6.97 
(d, J = 11.2 Hz, 1H), 6.57 (s, 1H), 3.65 (s, 3H), 3.61 (s, 3H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 162.4, 146.7, 140.4, 139.6, 137.8, 132.4, 129.5, 
128.3, 127.3, 127.2, 126.7, 125.7, 114.6, 112.2, 111.7, 108.1, 55.3, 45.9 (ppm).  
MS (EI): m/z = 106.3 (23), 181.8 (16), 224.4 (90), 226.5 (79), 344.1 (100), 345.7 (87), 
362.1 (M
+
, 15). 
IR (KBr):  = 3017, 2968, 2649, 2310, 2097, 1586, 1482, 1259, 972 (cm-1) 
HRMS (ESI): 362.1213, calcd. for [M+H
+
]: 362.1215. 
 
6-Nitro-1-methyl-3,4-diphenyl benzothiazine 1-oxide (76d) 
 
Following the general procedure, 1,2-benzothiazine 76d was obtained as reddish solid 
in 72% yield (134.7 mg). A gradient of n-hexane/EtOAc: 2/1 was applied as eluent for 
the flash column chromatography purification.  
Melting point: 125-127 
o
C 
1
H NMR (400 MHz, CDCl3)  = 8.17 (dd, J = 8.7, 2.2 Hz, 1H), 8.11 (d, J = 2.0 Hz, 
1H), 8.01 (d, J = 8.7 Hz, 1H), 7.36 – 7.25 (m, 5H), 7.18 – 7.09 (m, 5H), 3.77 (s, 3H) 
(ppm).  
13
C NMR (101 MHz, CDCl3)  = 150.0, 148.7, 139.5, 138.3, 136.4, 132.3, 129.7, 
129.0, 128.1, 127.7, 125.1, 121.8, 121.3, 119.9, 113.5, 45.0 (ppm).  
MS (EI): m/z = 104.7 (21), 152.4 (17), 181.8 (16), 245.4 (100), 377.6 (M
+
, 16). 
IR (KBr):  = 3016, 2933, 2336, 2110, 1889, 1739, 1559, 1446, 1254, 974 (cm-1) 
HRMS (ESI) 377.0962, calcd. for [M+H
+
]: 377.0960. 
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6-Chloro-1-methyl-3,4-diphenyl benzothiazine 1-oxide (76e) 
 
Following the general procedure, 1,2-benzothiazine 76e was obtained as bright yellow 
solid in 79% yield (144.5 mg). A gradient of n-hexane/EtOAc: 5/1 was applied as 
eluent for the flash column chromatography purification. 
Melting point: 163-165 
o
C. 
1
H NMR (600 MHz, CDCl3):  = 7.79 (d, J = 8.5 Hz, 1H), 7.37 (d, J = 8.5 Hz, 1H), 
7.26 (m, 5H), 7.17 (d, J = 1.9 Hz, 1H), 7.15 – 7.08 (m, 5H), 3.67 (s, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3):  = 147.6, 139.9, 138.9, 138.6, 137.0, 132.3, 129.5, 
128.5, 127.5, 127.4, 127.0, 126.4, 125.4, 125.0, 116.5, 112.1, 45.4 (ppm).  
MS (EI): m/z = 63.3 (27), 76.9 (100), 102.4 (76), 151.1 (14), 163.3 (15), 177.6 (13), 
182.3 (12), 246.9 (3). 
IR (KBr):  = 3015, 2923, 2323, 2071, 1891, 1739, 1559, 1446, 1254, 1094 (cm-1). 
HRMS (ESI): 366.0709, calcd. for [M+H
+
]: 366.0719. 
 
6-Bromo-1-methyl-3,4-diphenyl benzothiazine 1-oxide (76f) 
 
Following the general procedure, 1,2-benzothiazine 76f was obtained as bright yellow 
solid in 81% yield (166.2 mg). A gradient of n-hexane/EtOAc: 5/1 was applied as 
eluent for the flash column chromatography purification. 
Melting point: 207-208 
o
C. 
1
H NMR (600 MHz, CDCl3):  = 7.71 (d, J = 8.5 Hz, 1H), 7.51 (d, J = 17.5, 8.8 Hz, 
1H), 7.34 (t, J = 8.9 Hz, 1H), 7.30 – 7.22 (m, 5H), 7.18 – 7.03 (m, 5H), 3.66 (s, 3H) 
(ppm).  
13
C NMR (151 MHz, CDCl3)  = 147.6, 139.9, 138.6, 136.9, 132.3, 129.5, 129.2, 
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128.6, 128.5, 127.54, 127.52, 127.4, 127.1, 124.9, 116.9, 112.0, 45.3 (ppm).  
MS (EI): m/z = 51.7 (40), 76.9 (99), 103.5 (63), 105.2 (80), 120.6 (12), 138.3 (24), 
150.1 (46), 161.5 (87), 163.0 (76), 177.3 (22), 181.6 (84), 183.3 (100), 188.0 (29), 
208.9 (70), 211.8 (76), 409.6 (M
+
, 31). 
IR (KBr):  = 3008, 2922, 2315, 1739, 1571, 1461, 1199, 961 (cm-1) 
HRMS (ESI): 410.0210, calcd. for [M+H
+
]: 410.0214. 
 
1,3,4-Triphenyl benzothiazine 1-oxide (76g) 
 
Following the general procedure, 1,2-benzothiazine 76g was obtained as brownish 
thick oil in 85% yield (167.2 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as 
eluent for the flash column chromatography purification. 
1
H NMR (400 MHz, CDCl3)  = 8.11 (m, 2H), 7.68 – 7.57 (m, 3H), 7.41 – 7.19 (m, 
11H), 7.15 – 7.06 (m, 3H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 146.2, 140.7, 140.0, 138.0, 136.9, 133.6, 132.6, 
131.9, 129.85, 129.8, 129.1, 128.5, 127.4, 127.3, 126.9, 126.1, 125.8, 125.0, 119.6, 
112.8 (ppm).  
MS (EI): m/z = 51.7 (21), 163.0 (32), 177.3 (22), 181.6 (84), 183.3 (100), 188.0 (29), 
208.9 (70), 211.8 (76), 393.2 (M
+
, 6). 
IR (KBr):  = 3057, 2931, 1739, 1581, 1450, 1241, 1100, 911 (cm-1) 
HRMS (ESI): 394.1257, calcd. for [M+H
+
]: 394.1266.  
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1-Methyl-3,4-bis(4-methoxyphenyl) benzothiazine 1-oxide (76h) 
 
Following the general procedure, 1,2-benzothiazine 76h was obtained as pale yellow 
solid in 93% yield (182.1 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as 
eluent for the flash column chromatography.  
Melting point: 105-107 
o
C. 
1
H NMR (400 MHz, CDCl3)  = 7.84 – 7.79 (d, J = 20 Hz, 1H), 7.44 – 7.39 (m, 2H), 
7.24 – 7.20 (m, 3H), 7.06-7.04 (d, J = 8.0Hz, 2H), 6.85-6.83 (d, J = 8.0 Hz, 2H), 6.67 
– 6.65 (m, 2H), 3.80 (s, 3H), 3.72 (s, 3H), 3.65 (s, 3H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 158.6, 158.3, 145.5, 137.4, 133.4, 132.9, 132.2, 
131.0, 130.1, 126.0, 125.8, 123.2, 118.6, 113.9, 112.8, 111.7, 55.2, 55.1, 45.5 (ppm).  
MS (EI): m/z = 63.3 (27), 76.9 (100), 102.4 (76), 151.1 (14), 163.3 (15), 177.6 (13), 
182.3 (12), 246.9 (3), 391.6 (M
+
, 12). 
IR (KBr):  = 3010, 2835, 2283, 2058, 1964, 1893, 1739, 1596, 1454, 1229 (cm-1) 
HRMS (ESI): 392.1309, calcd. for [M+H
+
]: 392.1320. 
 
1-Methyl-3,4-bis(4-fluorophenyl) benzothiazine 1-oxide (76i) 
 
Following the general procedure, 1,2-benzothiazine 76i was obtained as pale yellow 
thick oil in 82% yield (150.6 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as 
eluent for the flash column chromatography. 
1
H NMR (600 MHz, CDCl3)  7.87 = (d, J = 7.9 Hz, 1H), 7.46 (m, 2H), 7.27 – 7.22 
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(m, 2H), 7.17 (d, J = 8.8 Hz, 1H), 7.09 (s, 2H), 6.99 (t, J = 8.6 Hz, 2H), 6.82 (t, J = 
8.7 Hz, 2H), 3.68 (s, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 162.6 (J C-F = 17.6 Hz), 161.0 (J C-F = 16.7 Hz), 
145.3, 136.7, 136.2 (J C-F = 3.3 Hz), 133.9 (J C-F = 7.8 Hz), 133.4 (J C-F = 3.5 Hz), 
132.5, 131.4 (J C-F = 8.1 Hz), 126.4, 125.8, 123.4, 118.7, 115.5 (J C-F = 20.9 Hz), 
114.5, 114.4, 111.6, 45.1 (ppm).  
19
F NMR (564 MHz, CDCl3)  = -114.2, -115.1 (ppm). 
MS (EI): m/z = 64.1 (35), 131.2 (100), 102.4 (76), 151.1 (14), 163.3 (15), 368.2 (M
+
, 
12). 
IR (KBr):  = 3023, 2319, 2049, 1739, 1593, 1461, 1366, 1210, 1098, 965 (cm-1). 
HRMS (ESI): 368.0913, calcd. for [M+H
+
]: 368.0921. 
 
1-Methyl-3,4-bis(4-chlorophenyl) benzothiazine 1-oxide (76j) 
 
Following the general procedure, 1,2-benzothiazine 76j was obtained as pale yellow 
solid in 86% yield (171.9 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as 
eluent for the flash column chromatography. 
Melting point: 185-187 
o
C. 
1
H NMR (600 MHz, CDCl3)  = 7.86 (d, J = 7.9 Hz, 1H), 7.47 (m, 2H), 7.27 (d, J = 
8.6 Hz, 2H), 7.22 – 7.18 (m, 2H), 7.15 (d, J = 8.2 Hz, 1H), 7.12 (m, 2H), 7.06 (d, J = 
7.7 Hz, 2H), 3.68 (s, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 145.0, 138.5, 136.4, 136.0, 133.7, 133.4, 133.0, 
132.6, 131.0, 128.8, 127.8, 126.6, 125.8, 123.4, 118.8, 111.7, 45.1 (ppm). 
MS (EI): m/z = 64.1 (35), 131.2 (100), 102.4 (76), 151.1 (14), 163.3 (15), 400.0 (M
+
, 
7). 
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IR (KBr):  = 3016, 2928, 2319, 2073, 1909, 1738, 1575, 1462, 1208, 1091, 968 
(cm
-1
). 
HRMS (ESI): 400.0327, calcd. for [M+H
+
]: 400.0330. 
 
1-Methyl-3,4-di(thiophen-2-yl) benzothiazine 1-oxide (76k) 
 
Following the general procedure, 1,2-benzothiazine 76k was obtained as yellow thick 
oil in 87% yield (149.4 mg). A gradient of n-hexane/EtOAc: 5/1 was applied as eluent 
for the flash column chromatography. 
1
H NMR (600 MHz, CDCl3)  = 7.80 (d, J = 9.0 Hz, 1H), 7.54 (d, J = 4.1 Hz, 1H), 
7.51 – 7.43 (m, 1H), 7.41 – 7.34 (m, 1H), 7.28 – 7.23 (m, 1H), 7.22 – 7.15 (m, 2H), 
7.00 (d, J = 3.4 Hz, 1H), 6.95 (d, J = 3.8 Hz, 1H), 6.89 – 6.85 (m, 1H), 3.64 (s, 3H) 
(ppm). 
13
C NMR (151 MHz, CDCl3)  = 143.3, 141.3, 138.6, 137.8, 132.7, 130.4, 129.1, 
128.5, 128.0, 127.9, 126.9, 126.2, 126.1, 123.1, 119.1, 102.5, 45.2 (ppm).  
MS (EI): m/z = 63.3 (27), 76.9 (100), 102.4 (76), 151.1 (14), 163.3 (15), 177.6 (13), 
182.3 (12), 246.9 (3). 
IR (KBr):  = 3072, 3011, 2924, 2327, 2100, 1738, 1567, 1460, 1306, 1219, 1078, 
965 (cm
-1
)
 
HRMS (ESI): 344.0230, calcd. for [M+H
+
]: 344.0238. 
 
1-Methyl-3,4-diethyl benzothiazine 1-oxide (76l) 
 
Following the general procedure, 1,2-benzothiazine 76l was obtained as brownish 
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thick oil in 67% yield (78.8 mg). A gradient of n-hexane/EtOAc: 5/1 was applied as 
eluent for the flash column chromatography. 
1
H NMR (600 MHz, CDCl3)  = 7.78 (d, J = 7.9 Hz, 1H), 7.63 – 7.55 (m, 2H), 7.39 (d, 
J = 6.6 Hz, 1H), 3.52 (s, 3H), 2.68 – 2.48 (m, 4H), 1.28 – 1.26 (t, J = 7.5 Hz, 3H), 
1.19 – 1.17 (t, J = 7.5 Hz, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 149.0, 136.2, 132.3, 124.9, 123.5, 123.2, 119.1, 
108.5, 44.4, 28.8, 20.4, 14.6, 13.3 (ppm).  
MS (EI): m/z = 64.1 (35), 148.2 (100), 178.6 (29), 235.2 (M
+
, 23). 
IR (KBr):  = 3057, 2959, 2331, 1737, 1579, 1454, 1230, 1098, 1025, 972 (cm-1) 
HRMS (ESI): 236.1109, calcd. for [M+H
+
]: 236.1109.  
 
1-Methyl-3,4-dipropyl benzothiazine 1-oxide (76m) 
 
Following the general procedure, 1,2-benzothiazine 76m was obtained as brownish 
thick oil in 72% yield (94.8 mg). A gradient of n-hexane/EtOAc: 5/1 was applied as 
eluent for the flash column chromatography. 
1
H NMR (600 MHz, CDCl3)  = 7.74 (d, J = 7.9 Hz, 1H), 7.57 (t, J = 8.4 Hz, 1H), 
7.52 (d, J = 8.3 Hz, 1H), 7.35 (t, J = 7.2 Hz, 1H), 3.48 (s, 3H), 2.57 – 2.38 (m, 4H), 
1.72 (m, 2H), 1.53 (m, 2H), 1.00 (m, 6H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 147.9, 136.4, 132.3, 124.9, 123.5, 119.1, 107.9, 44.4, 
37.5, 29.6, 23.2, 22.1, 14.4, 14.1(ppm).  
MS (EI): m/z = 123.1 (23), 163.2 (100), 192.6 (37), 263.2 (M
+
, 7). 
IR (KBr):  = 3047, 2949, 2326, 1745, 1580, 1245, 1087, 1025, 972 (cm-1). 
HRMS (ESI): 264.1413, calcd. for [M+H
+
]: 264.1422. 
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1,4-Dimethyl-3-phenyl benzothiazine 1-oxide and 1,3-dimethyl-4-phenyl 
benzothiazine 1-oxide (76n and 76n’) 
 
Following the general procedure, 1,2-benzothiazines 76n and 76n’ were obtained as 
pale yellow solid in a combined 82% yield (110.5 mg) with an isomeric ratio of 85:15, 
which was determined by 
1
H-NMR. A gradient of n-hexane/EtOAc: 5/1 was applied 
as eluent for the flash column chromatography. 
Melting point: 156-158 
o
C. 
1
H NMR (600 MHz, CDCl3)  = 7.83 (d, J = 7.5 Hz, 1H, major), 7.78 (d, J = 9.2 Hz, 
0.2H, minor), 7.70 – 7.64 (m, 2H, major), 7.55 – 7.53 (m, 2H, major), 7.47 (m, 1H, 
major), 7.41 (t, J = 6.8 Hz, 2H, major), 7.34 (m, 1H, major), 7.21 (d, J = 7.1 Hz, 0.2H, 
minor), 6.89 (d, J = 9.0 Hz, 0.1H, minor), 3.61 (s, 3H, major), 3.60 (s, 0.5H, minor), 
2.21 (s, 3H, major), 2.01 (s, 0.5H, minor) (ppm).  
13
C NMR (151 MHz, CDCl3, major+minor)  = 145.4, 145.0, 140.4, 136.9, 132.4, 
132.3, 129.7, 127.9, 127.0, 125.9, 125.5, 125.2, 124.3, 123.2, 123.0, 119.9, 104.4, 
45.1, 44.1, 23.8, 15.5 (ppm).  
MS (EI): m/z = 64.1 (35), 148.2 (100), 178.6 (29), 201.6 (13), 269.2 (M
+
, 27). 
IR (KBr):  = 3002, 2924, 2853, 1737, 1574, 1463, 1205 (cm-1). 
HRMS (ESI): 270.0964, calcd. for [M+H
+
]: 270.0953.  
 
4-Methyl carboxylate-1-methyl-3-phenyl benzothiazine 1-oxide (76o) 
 
Following the general procedure, 1,2-benzothiazine 76o obtained as pale yellow solid 
in 82% yield (128.4 mg). A gradient of n-hexane/EtOAc: 5/1 was applied as eluent for 
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the flash column chromatography. The structure was confirmed by NOESY. 
Melting point: 168-169 
o
C. 
1
H NMR (400 MHz, CDCl3)  = 7.96 (d, J = 8.4 Hz, 1H), 7.77 (d, J = 8.0 Hz, 1H), 
7.60 (t, J = 7.2 Hz, 1H), 7.52 (dd, J = 7.7, 1.8 Hz, 2H), 7.41 (t, J = 8.1 Hz, 1H), 7.37 – 
7.24 (m, 3H), 3.52 (s, 3H), 3.39 (s, 3H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 169.4, 152.8, 140.2, 133.8, 133.3, 129.0, 128.2, 
128.1, 126.7, 124.9, 123.4, 117.3, 105.4, 51.8, 45.0 (ppm).  
MS (EI): m/z = 58.1 (26), 131.2 (100), 178.6 (29), 201.6 (13), 269.2 (13). 
IR (KBr):  = 3011, 2637, 1737, 1564, 1464, 1358, 1278, 1203, 1128, 915 (cm-1). 
HRMS (ESI): 314.0849, calcd. for [M+H
+
]: 314.0851.  
 
3-(4-Methoxyphenyl)-1-methyl-4-phenyl benzothiazine 1-oxide  and 4-(4-methoxy-
phenyl)-1-methyl-3-phenyl benzothiazine 1-oxide (76p and 76p’) 
 
Following the general procedure, 1,2-benzothiazines 84p and 84p’ were obtained as 
pale yellow solid in a combined 90% yield (162.6 mg) with an isomeric ratio of 50:50, 
which was determined by 
1
H-NMR. A gradient of n-hexane/EtOAc: 5/1 was applied 
as eluent for the flash column chromatography. 
Melting point: 104-106 
o
C. 
1
H NMR (600 MHz, CDCl3)  = 7.85 (dd, J = 3.5, 1.3 Hz, 1H), 7.84 (dd, J = 3.5, 1.3 
Hz, 1H), 7.46 – 7.38 (m, 4H), 7.31 – 7.27 (m, 4H), 7.25 – 7.21 (m, 4H), 7.21 – 7.03 
(m, 8H), 6.82 (d, J = 8.6 Hz, 2H), 6.66 – 6.63 (m, 2H), 3.79 (s, 3H), 3.71 (s, 3H), 3.67 
(d, J = 2.0 Hz, 6H) (ppm).  
13
C NMR (151 MHz, CDCl3) = 158.9, 158.5, 146.1, 145.6, 140.6, 138.2, 137.4, 
137.2, 133.9, 133.5, 132.8, 132.6, 132.5, 131.2, 129.9, 129.7, 129.3, 128.6, 127.6, 
127.3, 126.9, 126.6, 126.3, 125.2, 123.9, 118.9, 118.6, 114.0, 112.9, 112.4, 55.32, 
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55.29, 45.29, 45.24 (ppm). 
MS (EI): m/z = 64.1 (35), 131.2 (100), 102.4 (76), 151.1 (14), 163.3 (15), 361.4 (M
+
, 
7). 
IR (KBr):  = 3014, 2927, 2837, 1740, 1594, 1505, 1458, 1241 (cm-1). 
HRMS (ESI): 362.1203, calcd. for [M+H
+
]: 362.1215.  
 
1-Methyl-3-(4-nitrophenyl)-4-phenyl benzothiazine 1-oxide and 1-methyl-4-(4-nitro-
phenyl)-3-phenyl benzothiazine 1-oxide (76q and 76q’) 
 
Following the general procedure, 1,2-benzothiazines 76q and 76q’ were obtained as 
brownish thick oil in a combined 80% yield (150.6 mg) with an isomeric ratio of 
50:50, which was determined by 
1
H-NMR. A gradient of n-hexane/EtOAc: 3/1 was 
applied as eluent for the flash column chromatography. 
1
H NMR (600 MHz, CDCl3, mixture)  = 8.13 (d, J = 8.9 Hz, 2H), 7.96 (d, J = 9.0 Hz, 
2H), 7.91 – 7.88 (m, 2H), 7.53 – 7.47 (m, 4H), 7.43 (d, J = 9.0 Hz, 2H), 7.33 – 7.28 
(m, 5H), 7.23 – 7.19 (m, 3H), 7.16 – 7.10 (m, 6H), 3.71 (s, 3H), 3.71 (s, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3, mixture)  = 147.3, 147.0, 146.53, 146.49, 145.6, 143.2, 
139.6, 136.7, 133.4, 132.8, 132.6, 132.2, 130.5, 129.4, 127.9, 127.8, 127.5, 127.1, 
126.6, 126.5, 125.2, 123.6, 123.5, 123.3, 122.6, 45.1, 45.0 (ppm).  
MS (EI): m/z = 63.3 (27), 76.9 (32), 102.4 (100), 151.1 (14), 163.3 (15), 177.6 (13), 
182.3 (12), 246.9 (3). 
IR (KBr):  = 3024, 2928, 1737, 1584, 1464, 1333, 1213, 1101, 972 (cm-1). 
HRMS (ESI): 377.0973, calcd. for [M+H
+
]: 377.0960.  
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1-Methyl-3-(naphthalen-1-yl)-4-phenyl benzothiazine 1-oxide and 1-methyl-4- 
(naphthalen-1-yl)-3-phenyl benzothiazine 1-oxide (76r and 76r’) 
 
Following the general procedure, 1,2-benzothiazines 76r and 76r’ were obtained as 
brownish thick oil in a combined 78% yield (148.8 mg) with an isomeric ratio of 
50:50, which was determined by 
1
H-NMR. A gradient of n-hexane/EtOAc: 5/1 was 
applied as eluent for the flash column chromatography. 
1
H NMR (600 MHz, CDCl3, mixture)  = 7.88 (d, J = 8.5 Hz, 1H), 7.85 (s, 1H), 7.70 
– 7.62 (m, 3H), 7.54 (d, J = 8.5 Hz, 1H), 7.49 – 7.32(m, 7H), 7.29 – 7.16 (m, 7H), 
7.07 – 7.03 (m, 1H), 3.73 (s, 3H), 3.72 (s, 1H) (ppm).  
13
C NMR (151 MHz, CDCl3, mixture)  = 146.3, 145.7, 140.2, 137.7, 137.68, 136.9, 
132.8, 132.5, 132.47, 132.4, 131.3, 130.6, 129.6, 129.4, 128.5, 128.4, 127. 9, 127.6, 
127.5, 127.46, 127.34, 127.32, 126.9, 126.6, 126.2, 126.16, 126.0, 125.9, 125.8, 125.7, 
123.3, 118.7, 118.66, 113.1, 112.6, 45.2, 45.1 (ppm).  
MS (EI): m/z = 63.3 (27), 76.9 (100), 102.4 (76), 151.1 (14), 163.3 (15), 177.6 (13), 
182.3 (12), 246.9 (3), 352.1 (27), 382.1 (M
+
, 17). 
IR (KBr):  = 3052, 2926, 1740, 1567, 1463, 1200, 982 (cm-1). 
HRMS (ESI): 383.1258, calcd. for [M+H
+
]: 382.1266. 
 
Sulfoximine 61a-d1:  
 
1
H NMR (600 MHz, CDCl3)  = 8.02 (d, J = 8.6 Hz, 1H), 7.62 (t, J = 7.4 Hz, 1H), 
7.56 (t, J = 7.0 Hz, 2H), 3.12 (s, 3H), 2.47 (s, NH) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 143.5, 133.3, 129.4, 129.3, 127.81, 127.59 
(JC-D=25.6Hz), 46.3 (ppm). 
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HRMS (ESI): 157.0536, calcd. for [M+H
+
]: 157.0546. 
 
1-Methyl-3,4-diphenyl benzothiazine 1-oxide (76a-d1+76a) 
 
Following the general procedure, 1,2-benzothiazines 76a-d1 and 76a were obtained as 
pale yellow solid in 56% yield. A gradient of n-hexane/EtOAc: 5/1 was applied as 
eluent for the flash column chromatography. 
1
H NMR (600 MHz, CDCl3)  = 7.87 (d, J = 7.2 Hz, 0.55H), 7.50 – 7.45 (m, 1H), 
7.45 – 7.40 (m, 1H), 7.31 – 7.21 (m, 5H), 7.18 – 7.08 (m, 5H), 3.69 (s, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 146.1, 140.4, 137.8, 137.0, 132.6, 132.5, 129.7, 
128.5, 127.5, 127.4, 126.9, 126.3, 126.2, 126.0, 123.3, 118.7, 112.8, 77.37, 77.16, 
76.95, 45.2 (ppm).  
HRMS (ESI): 333.1164, calcd. for [M+H
+
]: 333.1172. 
 
Crude Rhodacycle II:  
 
1
H NMR (600 MHz, CDCl3)  = 8.02 (d, J = 7.6 Hz, 2H), 7.83 (d, J = 7.7 Hz, 1H), 
7.60 (m, 3H), 7.40 (t, J = 7.3 Hz, 2H), 7.15 (t, J = 7.4 Hz, 1H), 3.32 (s, 3H), 3.14 (s, 
3H), 1.64 (s, 15H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 167.63 (JC-Rh = 32.3 Hz), 144.1, 138.5, 133.3, 129.5, 
127.9, 126.1, 124.1, 95.19, 50.22, 9.3 (ppm).  
IR: ν(B-F) = 1042 (cm-1). 
HRMS (ESI): 392.0542 (pos), 87.0036 (neg), calcd. for [C17H22NOSRh+H
+
]: 
392.0544 (pos), [BF4
-
]: 87.0035 (neg).  
 
 
Chapter 1 
56 
 
Rhodacycle II’:  
 
Following the described procedure, rhodacycle II’ was obtained as reddish solid. A 
gradient of n-hexane/EtOAc: 1/1 was applied as eluent for the flash column 
chromatography (neutral Al2O3). 
1
H NMR (600 MHz, CDCl3)  = 7.72 (d, J = 7.7 Hz, 1H), 7.36 (m, 2H), 7.11 (t, J = 
8.0 Hz, 1H), 3.27 (s, 3H), 1.74 (s, 15H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 166.21 (d, JC-Rh = 31.7 Hz), 143.2, 140.5, 133.0, 
125.9, 124.0, 96.0, 48.2, 10.0 (ppm).  
HRMS (ESI): 517.9552, calcd. for [C17H22NSOIRh]: 517.9522. 
 
N-Benzoyl-2-benzoyl-S-phenyl sulfoximine (77a) 
 
Following the described procedure, N-Benzoyl-2-benzoyl-S-phenyl sulfoximine 85a 
was obtained as white solid in 96% yield. EtOAc was applied as eluent for the flash 
column chromatography.  
Melting point: 150-151 
o
C. 
1
H NMR (600 MHz, CDCl3)  = 8.32 (d, J = 7.5 Hz, 1H), 7.78 – 7.70 (m, 4H), 7.55 (d, 
J = 8.3 Hz, 2H), 7.43 – 7.39 (m, 2H), 7.30 – 7.22 (m, 3H), 7.04 (t, J = 7.8 Hz, 2H), 
3.70 (s, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 195.6, 174.5, 139.3, 137.9, 135.7, 134.9, 134.1, 
133.0, 131.6, 130.8, 130.5, 130.1, 129.1, 128.9, 128.6, 127.5, 46.0 (ppm).  
MS (EI): m/z = 104.7 (16), 195.4 (35), 243.7 (100), 364.0 (M
+
, 2). 
IR(KBr):  = 3015, 2927, 2325, 1739, 1660, 1615, 1450, 1261, 984 (cm-1). 
HRMS (ESI): 364.1014, calcd. for [M+H
+
]: 364.1007. 
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N-Benzoyl-2-benzoyl-S-4-nitrophenyl sulfoximine (77b) 
 
Following the described procedure, N-Benzoyl-2-benzoyl-S-4-nitrophenyl 
sulfoximine 85b was obtained as white solid in 82% yield. EtOAc was applied as 
eluent for the flash column chromatography. 
Melting point: 179-181 
o
C. 
1
H NMR (400 MHz, CDCl3)  = 8.55 (d, J = 3.4 Hz, 2H), 8.23 (s, 1H), 7.71 (d, J = 
7.1 Hz, 2H), 7.57 (d, J = 7.1 Hz, 2H), 7.39 (t, J = 7.4 Hz, 1H), 7.33 – 7.21 (m, 4H), 
7.12 – 7.05 (m, 2H), 3.68 (s, 3H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 193.4, 174.5, 150.0, 144.2, 141.1, 134.9, 134.5, 
134.2, 132.3, 132.2, 130.8, 129.3, 128.9, 127.7, 125.2, 123.7, 46.1 (ppm). 
MS (EI): m/z = 105.1 (23), 195.4 (27), 243.7 (100), 409.1 (M
+
, 3). 
IR(KBr):  = 3015, 2610, 2184, 1665, 1615, 1448, 1368, 1264, 1123, 979 (cm-1). 
HRMS (ESI): 409.0863, calcd. for [M+H
+
]: 409.0858. 
 
N-Benzoyl-2-benzoyl-S-4-bromophenyl sulfoximine (77c) 
 
Following the described procedure, N-Benzoyl-2-benzoyl-S-4-bromophenyl 
sulfoximine 85c was obtained as white solid in 82% yield. EtOAc was applied as 
eluent for the flash column chromatography. 
Melting point: 171-173 
o
C. 
1
H NMR (400 MHz, CDCl3)  = 8.16 (d, J = 8.5 Hz, 1H), 7.87 (dd, J = 8.5, 2.0 Hz, 
1H), 7.73 (d, J = 7.1 Hz, 2H), 7.55 (dd, J = 6.4, 5.1 Hz, 3H), 7.40 (t, J = 7.4 Hz, 1H), 
7.31 – 7.22 (m, 3H), 7.05 (t, J = 7.8 Hz, 2H), 3.65 (s, 3H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 194.0, 174.4, 140.8, 137.0, 135.1, 134.7, 134.4, 
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133.7, 131.8, 131.76, 131.67, 130.8, 129.2, 128.7, 128.4, 127.6, 46.3 (ppm).  
MS (EI): m/z = 105.1 (13), 195.4 (25), 243.7 (90), 443.1 (M
+
, 3). 
IR(KBr):  = 3019, 2601, 2320, 1739, 1666, 1615, 1450, 1370, 1219, 1118, 984 
(cm
-1
). 
HRMS (ESI): 444.0075, calcd. for [M+H
+
]: 444.0092. 
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Part III Rhodium-Catalyzed Sulfoximine-Directed ortho-C-H 
Addition Reaction 
 
1 Research Objective 
 
Until now, several examples of metal-catalyzed directing group-assisted C-H 
additions to activated alkenes or inactivated alkenes have been reported. However, the 
ortho-C-H addition to heterobicyclic alkenes has not yet been well documented. 
Bicyclic alkenes such as oxa- and azabenzonorbornadienes, can be readily activated 
by transition metal complexes. Thus Bolm’s group demonstrated an example of 
rhodium-catalyzed intermolecular hydroacylation reaction of salicylaldehydes with 
1,4-epoxy-1,4-dihydro naphthalenes to give ketone products in moderate to good 
yields (Scheme 41, eq. A).
[43] 
In this chapter we will disclose an ortho-alkylation 
reaction of NH-sulfoximines with heterobicyclic alkenes by a new Rh(III)-catalyzed 
C-H bond activation pathway (Scheme 41, eq. B). 
 
Scheme 41 Research objective 
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2 Results and Discussions 
 
The reaction of NH-sulfoximine 61a with oxa-bicyclic alkene 79a under 
annulation reaction conditions (Table 3, on page 33) gave the addition product 81a in 
only 62% yield. Interestingly, elevated reaction temperature (120 
o
C) increased the 
yield dramatically, affording the addition product in 89% yield (Scheme 42).  
 
Scheme 42 Temperature influence on the reaction 
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3 Substrate Scope 
 
Table 4 Substrate scope 
 
Entry 61 79 81 R
1
 Yield (%) 
1 61a 79a 
 
81a: R
1
 = H 89 
2 61b 79a 81b: R
1
 =3-Me 90 
3 61c 79a 81c: R
1
 = 4-OMe 92 
4 61d 79a 81d: R
1
 = 4-NO2 72 
5 61e 79a 81e: R
1
 = 4-Cl 79 
6 61f 79a  81f: R
1
 = 4-Br 79 
7 61h 79a  81g: R
1
 = 4-Me 88 
8 61i 79a 
 
81h 79 
9 61j 79a 
 
81i: R
1
 = Et 88 
10 61k 79a 81j: R
1
 = i-Pr 78 
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11 61a 79b 
 
81k 78 
12 61a 79c 
 
81l 80 
13 61a 79d 
 
81m 82 
Notes: [a] Conditions: NH-sulfoximine 61 (0.30 mmol), oxabicyclic 79 (0.36 
mmol), [Cp*Rh(MeCN)3][BF4]2 (5.0 mol %), Fe(OAc)2 (20 mol %), toluene 
(2.5 mL), 120 °C, 4 h.  
 
Under standard reaction conditions, we examined the scope of the present reaction 
by using a variety of NH-sulfoximines (61a-f and 61h-k) with oxabicyclic alkenes 
(79a-d) (Table 4). Thus, the reaction of meta-methylphenyl NH-sulfoximine (61b) 
with 134a gave the regioselective product 136b in good yield (90%). Substrates wuth 
electron donating substituents such as 4-methoxyphenyl and 4-methylphenyl 
NH-sulfoximines (61h and 61c) underwent the C-H addition reaction with alkene 79a, 
affording the desired products 81c and 81g in 92% and 88% yields (entries 3 and 7). 
Halogen substituted NH-sulfoximines were compatible with the present reaction 
conditions. Interestingly, S-4-chlorophenyl-, and S-4-bromophenyl-S-methyl 
NH-sulfoximines 61e-f reacted well with alkene 79a to give the desired products 
81e-f in 79% yield equally (entries 5-6). Notably, electron withdrawing substituent 
such as S-4-nitrophenyl-S-methyl NH-sulfoximine gave a moderate yield (72% for 
entry 4). The reaction of 2-naphthyl NH-sulfoximine (61h) with 79a, afforded 81h in 
79% yield (entry 6). In this case, there were two possible C-H bond activation sites at 
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C1 and C3 positions of 61h. However, the activation occured exclusively at C3 
position, most likely due to the steric influence of the fused aromatic ring. The effect 
of other substituents on the yields were also investigated. Thus, S-phenyl-S-ethyl 
sulfoximine (61i) and S-phenyl-S-isopropyl sulfoximine (61j) reacted with 79a 
providing 81i and 81j in 88% and 78% yields, respectively (entries 9-10). The scope 
of the C-H activation/addition reaction was further extended to various bicyclic 
alkenes. Thus, bulky 1,4-oxa-1,4-dihydrotriphenylene (79b) reacted well with 61a to 
afford the corresponding addition product 81k in 78% yield (entry 11). In a similar 
manner, the reaction of electron donating 6,7-methylenedioxy alkene 79c reacted with 
61a affording the ortho-alkylation product 81m in 80% yield (entry 13). Interestingly, 
7-azabenzonorbornadine 79d reacted smoothly with 61a to give 81m in good yield 
(82% for entry 13). In addtion the structure of 81m was further confirmed by single 
crystal X-ray diffraction (Figure 5). 
 
Figure 5 ORTEP Diagram and X-ray Data of of 81n (CCDC No. 945223) 
 
 
 
4 Summary 
 
In summary, we have developed a rhodium-catalyzed process for the synthesis of 
tetrahydro-epoxynaphthyl substituted sulfoximines from NH-sulfoximines and 
alkenes. The combination of simple Fe(OAc)2 (20 mol %) and O2 (1 atm) allows the 
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metal reoxidation to close the catalytic cycle. The method is high-yielding and 
suitable for the synthesis of various functionalized tetrahydro-epoxynaphthyl 
sulfoximines. 
 
5 Experimental Part 
 
A Schlenk tube (20 mL) equipped with a stirring bar was loaded with the 
NH-sulfoximine (0.5 mmol), oxabicyclic alkene (0.6 mmol), [Cp*Rh(MeCN)3][BF4]2 
(13.5 mg, 0.025 mmol, 5 mol %) and Fe(OAc)2 (18 mg, 0.1 mmol, 20 mol %). Under 
an oxygen atmosphere (1 atm), dry toluene (3.0 mL) was added, and the reaction 
mixture was allowed to stir at 120 °C for 4 h. After cooling to room temperature, the 
mixture was filtered through a short celite pad and washed with dichloromethane (3 × 
20 mL). The filtrate was concentrated, and the product was purified by flash column 
chromatography using silica gel with a mixture of hexane and ethyl acetate as eluent. 
 
6 Data and Characterization 
 
S-Phenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthyl) sulfoximine (81a) 
 
Following the general procedure, product 81a was obtained as off-white foamy solid 
in 85% yield (127.2 mg). A gradient of n-hexane/EtOAc: 3/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 69-71 
o
C 
1
H NMR (600 MHz, CDCl3)  = 8.11 (d, J = 6.6 Hz, 1H), 7.89 (d, J = 7.9 Hz, 1H), 
7.60 (t, J = 7.6 Hz, 1H), 7.40 – 7.35 (m, 1H), 7.32 – 7.26 (m, 2H), 7.20 – 7.16 (m, 2H), 
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5.58 (d, J = 4.8 Hz, 1H), 5.20 (s, 1H), 4.02 (dd, J = 8.4, 4.5 Hz, 1H), 3.06 (s, 3H), 
2.65(br, NH), 2.19 – 2.10 (m, 2H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 145.8, 145.6, 145.0, 141.7, 133.7, 129.5, 129.0, 
127.04, 126.98, 126.8, 119.23, 119.20, 85.7, 79.2, 45.6, 41.2, 38.6 (ppm). 
MS (EI): m/z = 63.1 (28), 78.2 (19), 89.1 (30), 118.1 (100), 165.1 (11), 299.1 (M
+
, 
0.8). 
IR (KBr):  = 3269, 3005, 1740, 1585, 1459, 1359, 1217, 1118, 1064, 984, 934 
(cm
-1
). 
HRMS (ESI): 300.1058, calcd. for [M+H
+
]: 300.1053.  
 
S-5-Methylphenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthyl) 
sulfoximine (81b) 
 
Following the general procedure, product 81b was obtained as off-white foamy solid 
in 90% yield (141.1 mg). A gradient of n-hexane/EtOAc: 3/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 156-158 
o
C
 
1
H NMR (600 MHz, CDCl3)  = 7.92 (s, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.40 (d, J = 
8.0 Hz, 1H), 7.31 – 7.23 (m, 2H), 7.20 – 7.14 (m, 2H), 5.56 (d, J = 4.6 Hz, 1H), 5.17 
(s, 1H), 3.97 (dd, J = 8.3, 4.6 Hz, 1H), 3.04 (s, 3H), 2.57 (br, NH), 2.39 (s, 3H), 2.15 – 
2.07 (m, 2H) (ppm).
   
13
C NMR (151 MHz, CDCl3)  = 145.9, 145.7, 141.8, 141.4, 136.9, 134.5, 129.5, 
129.4, 127.0, 126.95, 119.2, 119.19, 85.8, 79.2, 45.7, 40.9, 38.6, 20.9 (ppm). 
MS (EI): m/z = 89.1 (17), 118.1 (100), 164.1(10), 180.2 (10), 202.2 (10), 234.2 (18), 
250.3 (20), 296.2 (11), 314.3 (M
+
, 20). 
IR (KBr):  = 3248, 3012, 2287, 2172, 1740, 1457, 1366, 1221, 1103, 1066, 996 
(cm
-1
). 
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HRMS (ESI): 314.1209, [M+H
+
]: 314.1209. 
 
S-4-Methoxyphenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthyl) 
sulfoximine (81c) 
 
Following the general procedure, product 81c was obtained as off-white foamy solid 
in 92% yield (151.5 mg). A gradient of n-hexane/EtOAc: 3/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 150-152 
o
C 
1
H NMR (600 MHz, CDCl3)  = 8.06 (d, J = 8.9 Hz, 1H), 7.41 (s, 1H), 7.32 – 7.27 (m, 
2H), 7.21 – 7.15 (m, 2H), 6.85 (d, J = 6.2 Hz, 1H), 5.56 (s, 1H), 5.22 (s, 1H), 3.99 (dd, 
J = 8.1, 4.7 Hz, 1H), 3.88 (s, 3H), 3.05 (s, 3H), 2.48 (br, NH), 2.16 – 2.10 (m, 2H) 
(ppm).
  
13
C NMR (151 MHz, CDCl3)  = 163.7, 147.4, 145.9, 145.6, 133.6, 131.6, 127.1, 
127.0, 119.3, 119.2, 115.2, 111.5, 85.7, 79.2, 55.7, 46.1, 41.4, 38.8 (ppm). 
MS (EI): m/z = 89.1 (11), 118.1 (100), 182.3 (14), 266.3 (43), 331.4 (M
+
, 1). 
IR (KBr):  = 3306, 3003, 2284, 1739, 1565, 1461, 1365, 1290, 1219, 1113, 1067, 
987, 938 (cm
-1
). 
HRMS (ESI): 330.1151, calcd. for [M+H
+
]: 330.1158. 
 
S-4-Nitrophenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthalene) 
sulfoximine (81d) 
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Following the general procedure, product 81d was obtained as pale yellow foamy 
solid in 72% yield (124.0 mg). A gradient of n-hexane/EtOAc: 3/1 was applied as 
eluent for the flash column chromatography purification. 
Melting point: 164-166 
o
C 
1
H NMR (400 MHz, CDCl3)  = 8.73 (s, 1H), 8.34 (d, J = 8.7 Hz, 1H), 8.20 (d, J = 
6.4 Hz, 1H), 7.35 – 7.30 (m, 2H), 7.24 – 7.19 (m, 2H), 5.68 (d, J = 4.3 Hz, 1H), 5.24 
(s, 1H), 4.08 (dd, J = 7.9, 4.8 Hz, 1H), 3.12 (s, 3H), 2.23 – 2.15 (m, 2H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 151.1, 147.8, 147.4, 145.8, 145.0, 130.7, 127.4, 
127.3, 124.7, 121.6, 119.5, 85.6, 79.4, 45.6, 41.8, 39.0 (ppm). 
MS (EI): m/z = 89.2 (15), 118.2 (90), 164.0 (3), 189.3 (8), 327.3 (2). 
IR (KBr):  = 3314, 3017, 2945, 1739, 1521, 1457, 1347, 1218, 1118, 982, 928 
(cm
-1
). 
HRMS (ESI): 345.0893, calcd. for [M+H
+
]: 345.0904. 
 
S-4-chlorophenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthalene) 
sulfoximine (81e) 
 
Following the general procedure, product 81e was obtained as off-white foamy solid 
in 79% yield (131.9 mg). A gradient of n-hexane/EtOAc: 3/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 88-90 
o
C 
1
H NMR (600 MHz, CDCl3)  = 8.04 (d, J = 8.6 Hz, 1H), 7.88 (s, 1H), 7.35 (d, J = 
8.6 Hz, 1H), 7.31 – 7.27 (m, 2H), 7.21 – 7.15 (m, 2H), 5.58 (d, J = 3.8 Hz, 1H), 5.20 
(s, 1H), 3.98 (dd, J = 7.5, 5.4 Hz, 1H), 3.04 (s, 3H), 2.66 (br, NH), 2.13 – 2.11 (m, 2H) 
(ppm).
  
13
C NMR (151 MHz, CDCl3)  = 147.0, 145.8, 145.3, 140.3, 140.2, 130.7, 129.6, 
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127.1, 127.0, 119.3, 119.2, 85.5, 79.2, 45.7, 41.3, 38.8 (ppm). 
MS (EI): m/z = 89.1 (6.0), 118.1 (100), 189.1 (6), 334.2 (1) . 
IR (KBr):  = 3453, 3270, 3008, 2931, 2283, 1739, 1566, 1457, 1388, 1218, 1057, 
984, 938 (cm
-1
). 
HRMS (ESI): 334.0669, calcd. for [M+H
+
]: 334.0663.
 
 
S-4-Bromophenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthalene) 
sulfoximine (81f) 
 
Following the general procedure, product 81f was obtained as off-white foamy solid 
in 79% yield (149.4 mg). A gradient of n-hexane/EtOAc: 3/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 84-86 
o
C
 
1
H NMR (600 MHz, CDCl3)  = 8.02 (s, 1H), 7.96 (d, J = 8.5 Hz, 1H), 7.51 (d, J = 
6.5 Hz, 1H), 7.31 – 7.26 (m, 2H), 7.20 – 7.15 (m, 2H), 5.58 (d, J = 4.0 Hz, 1H), 5.20 
(s, 1H), 3.96 (dd, J = 7.9, 4.9 Hz, 1H), 3.03 (s, 3H), 2.82 (br, NH), 2.14 – 2.09 (m, 2H) 
(ppm).
  
13
C NMR (151 MHz, CDCl3)  = 206.6, 205.9, 147.1, 145.7, 145.3, 140.8, 132.5, 
130.7, 130.1, 128.9, 127.1, 119.3, 119.2, 85.4, 79.2, 45.6, 41.3, 38.8 (ppm). 
MS (EI): m/z = 89.1 (6.5), 118.1 (100), 189.1 (11), 230.0 (9), 380.3 (M
+
, 1.4). 
IR (KBr):  = 3269, 3005, 2929, 2178, 1739, 1552, 1457, 1383, 1219, 1124, 1056, 
986, 937 (cm
-1
). 
HRMS (ESI): 380.0150, calcd. for [M+H
+
]: 380.0143. 
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S-4-methylphenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthalene) 
sulfoximine (81g) 
 
Following the general procedure, product 81g was obtained as off-white foamy solid 
in 88% yield (137.9 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 72-74 
o
C 
1
H NMR (400 MHz, CDCl3)  = 7.92 (d, J = 8.1 Hz, 1H), 7.61 (s, 1H), 7.24 – 7.18 (m, 
2H), 7.14 – 7.07 (m, 3H), 5.51 (d, J = 4.7 Hz, 1H), 5.13 (s, 1H), 3.91 (dd, J = 8.3, 4.6 
Hz, 1H), 2.97 (s, 3H), 2.36 (s, 3H), 2.54 (br, NH), 2.12 – 2.00 (m, 2H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 145.9, 145.7, 144.8, 144.6, 138.9, 130.0, 129.3, 
127.5, 127.04, 126.96, 119.24, 119.20, 85.7, 79.2, 45.8, 41.1, 38.5, 21.7(ppm). 
MS (EI): m/z = 63.1 (17), 77.8 (30), 89.4 (75), 117.6 (100). 
IR (KBr):  = 3275, 3005, 2934, 2249, 1740, 1597, 1457, 1366, 1280, 1215, 1057, 
986 (cm
-1
). 
HRMS (ESI): 314.1207, calcd. for [M+H
+
]: 314.1209. 
 
S-2-Naphthyl-S-methyl-3-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthalene) 
sulfoximine (81h) 
 
Following the general procedure, product 81h was obtained as off-white foamy solid 
in 79% yield (138.0 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as eluent for 
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the flash column chromatography purification. 
Melting point: 179-181 
o
C 
1
H NMR (600 MHz, CDCl3)  = 8.73 (s, 1H), 8.31 (s, 1H), 7.94 (dd, J = 13.5, 8.2 Hz, 
2H), 7.66 – 7.61 (m, 1H), 7.59 – 7.54 (m, 1H), 7.37 – 7.30 (m, 2H), 7.24 – 7.19 (m, 
2H), 5.67 (d, J = 4.9 Hz, 1H), 5.30 (s, 1H), 4.06 (dd, J = 8.5, 4.3 Hz, 1H), 3.15 (s, 3H), 
2.61 (br, NH), 2.35 – 2.19 (m, 2H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 146.0, 145.8, 140.1, 135.7, 130.9, 130.8, 129.2, 
129.1, 128.9, 127.8, 127.2, 127.1, 127.0, 119.5, 119.3, 86.2, 79.4, 45.7, 41.4, 39.2 
(ppm). 
MS (EI): m/z = 89.2 (10), 118.2 (100), 164.0 (9), 351.0 (1). 
IR (KBr):  = 3280, 3005, 2945, 1739, 1521, 1462, 1345, 1216, 1109, 936 (cm-1). 
HRMS (ESI): 350.1198, calcd. for [M+H
+
]: 350.1209. 
 
S-Phenyl-S-ethyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthalene) sulfoximine (81i) 
 
Following the general procedure, product 81i was obtained as off-white foamy solid 
in 88% yield (137.9 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 149-151 
o
C 
1
H NMR (600 MHz, CDCl3)  = 8.08 (d, J = 9.3 Hz, 1H), 7.91 (d, J = 9.0 Hz, 1H), 
7.60 (t, J = 7.6 Hz, 1H), 7.39 (t, J = 7.6 Hz, 1H), 7.33 – 7.26 (m, 2H), 7.23 – 7.15 (m, 
2H), 5.58 (d, J = 4.8 Hz, 1H), 5.19 (s, 1H), 4.06 (dd, J = 8.4, 4.5 Hz, 1H), 3.20 – 3.06 
(m, 2H), 2.61 (br, NH), 2.19 – 2.07 (m, 2H), 1.24 (t, J = 7.4 Hz, 3H) (ppm).  
13
C NMR (151 MHz, CDCl3)  = 145.9, 145.7, 145.5, 139.7, 133.8, 130.4, 129.6, 
127.1, 127.0, 126.8, 119.3, 85.8, 79.3, 51.5, 41.2, 38.8, 7.9 (ppm). 
MS (CI): m/z = 324.1. 
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IR (KBr):  = (cm-1). 
HRMS (ESI):324.1207, calcd. for [M+H
+
]: 314.1209. 
 
S-Phenyl-S-isopropyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’-epoxynaphthalene) sulfoximine 
(81j) 
 
Following the general procedure, product 81j was obtained as off-white foamy solid 
in 78% yield (127.9 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 117-119 
o
C 
1
H NMR (600 MHz, CDCl3)  = 8.06 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 7.3 Hz, 1H), 
7.58 (t, J = 7.6 Hz, 1H), 7.37 (t, J = 8.1 Hz, 1H), 7.28 (dd, J = 8.9, 5.8 Hz, 2H), 7.21 – 
7.15 (m, 2H), 5.57 (d, J = 4.8 Hz, 1H), 5.16 (s, 1H), 4.13 (dd, J = 8.5, 4.4 Hz, 1H), 
3.15 (dt, J = 13.6, 6.8 Hz, 1H), 2.58 (br, NH), 2.20 – 2.03 (m, 2H), 1.27 (dd, J = 6.8, 
3.9 Hz, 6H) (ppm).
  
13
C NMR (151 MHz, CDCl3)  = 146.0, 145.8, 145.7, 138.6, 133.6, 131.0, 129.6, 
127.0, 126.9, 126.5, 119.2, 118.18, 85.9, 79.2, 56.1, 41.1, 38.7, 16.2, 15.7 (ppm). 
MS (EI): m/z = 87.6 (27), 118.1 (100), 183.0 (17), 328.1 (M
+
, 3). 
IR (KBr):  = 3226, 3005, 2956, 2170, 1739, 1449, 1366, 1217, 1072, 983 (cm-1). 
HRMS (ESI): 328.1365, calcd. for [M+H
+
]: 328.1366. 
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S-phenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-1’,4’- epoxytriphenylene)sulfoximine 
(81k) 
 
Following the general procedure, product 81k was obtained as yellow foamy solid in 
78% yield (155.8 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 215-217 
o
C 
1
H NMR (400 MHz, CDCl3)  = 8.77 (t, J = 7.9 Hz, 2H), 8.14 (t, J = 6.7 Hz, 2H), 
7.95 (d, J = 9.2 Hz, 2H), 7.78 – 7.57 (m, 5H), 7.44 (t, J = 8.3 Hz, 1H), 6.19 (d, J = 4.3 
Hz, 1H), 5.88 (s, 1H), 4.06 (dd, J = 8.1, 4.4 Hz, 1H), 2.97 (s, 3H), 2.31 – 2.18 (m, 2H) 
(ppm).
  
13
C NMR (101 MHz, CDCl3)  = 145.3, 141.8, 141.5, 140.9, 134.0, 130.5, 130.4, 
129.9, 129.0, 127.2, 127.1, 126.9, 126.6, 125.9, 125.6, 124.4, 124.2, 123.8, 123.7, 
85.2, 78.7, 45.6, 41.6, 39.5 (ppm). 
MS (EI): m/z = 88.9 (25), 118.1 (100), 164.0 (35). 
IR (KBr):  = 3015, 2956, 2145, 1745, 1376, 1333, 1217, 1086, 989 (cm-1). 
HRMS (ESI): 400.153, [M+H
+
]: 400.1366. 
 
S-Phenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-6’,7’-dioxole-1’,4’-epoxynaphthalene) 
sulfoximine (81l) 
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Following the general procedure, product 81l was obtained as off-white foamy solid 
in 80% yield (137.4 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 151-153 
o
C. 
1
H NMR (600 MHz, CDCl3) δ = 8.12 (d, J = 7.9 Hz, 1H), 7.86 (d, J = 7.8 Hz, 1H), 
7.60 (t, J = 7.6 Hz, 1H), 7.40 (t, J = 7.6 Hz, 1H), 6.81 (d, J = 11.6 Hz, 2H), 5.96 (d, J 
= 19.2 Hz, 2H), 5.50 (d, J = 4.6 Hz, 1H), 5.13 (s, 1H), 3.96 (dd, J = 8.3, 4.4 Hz, 1H), 
3.10 (s, 3H), 2.68 (br, NH), 2.14 – 2.05 (m, 2H) (ppm).  
13
C NMR (151 MHz, CDCl3) δ = 146.8, 146.7, 145.1, 139.6, 139.5, 133.9, 129.5, 
129.1, 126.9, 101.7, 101.66, 101.4, 45.7, 41.6, 39.0 (ppm). 
MS (EI): m/z = 89.2 (10), 118.2 (90), 164.0 (9). 
IR (KBr):  = 3256, 2986, 2156, 1755, 1367, 1215, 1073, 986 (cm-1). 
HRMS (ESI): 366.0760, calcd. for [M+Na
+
]: 366.0770. 
 
S-Phenyl-S-methyl-2-(1’,2’,3’,4’-tetrahydro-9’-carboxylic acid methyl ester -1’,4’-
imine- naphthalene) sulfoximine (81m) 
 
Following the general procedure, product 81m was obtained as off-white foamy solid 
in 82% yield (146.1 mg). A gradient of n-hexane/EtOAc: 4/1 was applied as eluent for 
the flash column chromatography purification. 
Melting point: 168-170 
o
C 
1
H NMR (400 MHz, CDCl3)  = 8.15 (d, J = 8.0 Hz, 1H), 7.85 (d, J = 7.5 Hz, 1H), 
7.60 (t, J = 7.6 Hz, 1H), 7.41 (t, J = 8.2 Hz, 1H), 7.36 – 7.28 (m, 2H), 7.22 – 7.13 (m, 
2H), 5.37 (s, 1H), 5.05 (s, 1H), 3.95 (dd, J = 8.7, 4.5 Hz, 1H), 3.57 (s, 3H), 3.07 (s, 
3H), 2.46 (br, NH), 2.36 – 1.96 (m, 2H) (ppm).  
13
C NMR (101 MHz, CDCl3)  = 156.7, 144.0, 133.8, 129.5, 129.0, 127.3, 127.16, 
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127.11, 120.3, 68.2, 61.5, 52.8, 45.8 (ppm). 
MS (EI): m/z = 89.2 (10), 118.2 (100), 164.0 (9), 357.0 (M
+
, 1). 
IR (KBr):  = 3242, 3003, 2170, 1739, 1449, 1366, 1217, 1072, 973 (cm-1).. 
HRMS (ESI): 357.1263, calcd. for [M+H
+
]: 357.1267. 
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Enantioselective Synthesis of Dihydropyrazoles 
by Formal [4+1] Cycloaddition of  
in Situ-Derived Azoalkenes and Sulfur Ylides 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author contributions: Wanrong Dong synthesized the sulfur ylides 125a-d, 
performed the experiments for substrate scope table 8, entries 1-4. 
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1 General Introduction  
 
1.1 General Introduction of Dihydropyrazole Compounds 
 
Dihydropyrazoles, a catalogue of five-membered aza-heterocyclic compounds, 
have attracted great attention not only in pharmaceutical applications but also in the 
natural products synthesis.
[44]
 In addition, the dihydropyrazoles have been used as key 
building blocks for a wide range of compounds with excellent bioactivities for 
anti-depression, anti-cancer and anti-inflammatory. Moreover, some moleculars have 
been identified as good anti-diabetic, anaesthetic, analgesic agents with potential 
selective activities such as Nitric Oxide Synthase (NOS) inhibitor and Cannabinoid 
CB1 receptor antagonist activities. For example, compound 82 was tested to be the 
most active agent against Mycobacterium tuberculosis (MTB), while the compound 
83 showed good antimicrobial activity against Escherichia coli and Aspergillus niger 
diseases (Scheme 43). 
 
Scheme 43 Some biological active pyrazoline-cored compounds 
 
 
 
Previously, numerous examples have been reported for the synthesis of 
dihydropyrazole. Most of the reported protocols utilize asymmetric 1,3-dipolar 
cycloaddition (1,3-DC) reactions for the preparations of the five-membered 
compounds, and this methodology dominate the field today. 1,3-Dipoles such as 
diazomethanes, azomethine imines and nitrile imines have been frequently utilized as 
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the coupling partners ever since the first example from Fischer and Knövenagel.
[45] 
In 
this chapter, we will introduce some transition metal-catalyzed [3+2] cycloaddition 
reactions towards pyrazoles or pyrazolines. 
 
1.1.1 Diazoalkanes as Substrates for Pyrazoles by [3+2] Cycloadditions 
 
In 2000, the first examples of a 1,3-cycloaddition reactions between diazoalkanes 
with acrylamides were reported by Kanemasa and Kanai.
[46]
 Diazomethanes were 
utilized in the Lewis acid-catalyzed transformation without fatal deactivation of the 
catalyst. For example, trimethylsilyl diazomethane (84) reacted with dipolarophiles 
85a-c in the presence of a (R,R)-DBFOX/Ph metal complex (Scheme 44), giving the 
desired 2-pyrazolines in high yields (up to 93%) with excellent ee (up to 99%) 
(Scheme 44). 
 
Scheme 44 R,R-DBFOX/Ph-catalyzed [3+2] cycloaddition reaction 
 
 
 
Ever since the pioneering work, Lewis acid-catalyzed asymmetric [3+2] 
cycloaddition reactions between 1,3-dipoles such as diazoalkanes, azomethine imines 
or nitrile imines with unsaturated aldehydes, ketones or esters have been well 
documented.  
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In this context, Maruoka and coworkers disclosed examples of [3+2] 
cycloaddition reactions between diazoacetates and monodentate α-substituted 
acroleins. In the presence of chiral titanium/BINOLate complexes 90a-c,
[47]
 the 
asymmetric cycloaddition reaction afforded an easy access to highly functionalized 
pyrazoline adducts in good yields. The importance of the pyrazolines was 
demonstrated by a short synthesis of manzacidin A (Scheme 66). The system gave 
remarkably good yields and good enantioselectivities, without tedious protection and 
deprotection steps (Scheme 45). 
 
Scheme 45 Chiral titanium/BINOLate complexes-catalyzed [3+2] cycloaddition 
reaction 
 
 
 
Similarly, Sibi and coworkers developed a [3+2] cycloaddition of diazoesters with 
α,β-unsaturated pyrazolidinone imides towards pyrazoline derivatives in good yields 
(up to 91%) with high ee ( up to 99%).
[48]
 The advantages for the new system lay in 
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the elevated reaction temperature, and better rotamer geometry control. However, the 
restriction on the α-substituted acroleins remained unsolved (Scheme 46).  
 
Scheme 46 BOX liganded-Mg-catalyzed [3+2] cycloaddition reaction 
 
 
To surmount these shortcomings, chiral (S)-oxazaborolidinium ions (97a-c) were 
utilized as catalysts for the [3+2] cycloaddition reaction between unsaturated 
aldehydes
 
with α-substituted and α,β-disubstituted acroleins.[49] The methodology 
gave the desired adducts in good yields with excellent ee (96a-c in Scheme 47). The 
author credited the good results to the coordination between the catalysts and 
aldehyde substrates.
[50]
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Scheme 47 Oxazaborolidines-catalyzed [3+2] cycloaddition reaction 
  
 
 
1.1.2 Azomethine Imines as Substrates for Pyrazoles by [3+2] 
Cycloadditions 
 
Previously, the use of azomethine imines in asymmetric cycloaddition reactions is 
limited, and the attention has been focused on the use of azomethine imines for the 
stereoselective synthesis of five-membered heterocyclic compounds such as 
1,2,3-triazoles or β-lactams. 
Shintani and Fu developed a new combination of 
Cu(I)/phosphaferroceneoxazoline for the [3+2] cycloaddition reaction between 
azomethine imines with terminal alkynes, affording enantioselective bi-heterocyclic 
pyrazolidinones in excellent yields with good ee under mild conditions (Scheme 
48).
[51]
 Notably, aromatic, alkenyl and alkyl substituted azomethine imines reacted 
well in the system. Electron-poor terminal alkynes gave better results than 
electron-rich terminal alkynes. 
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Scheme 48 Cu(I)/phosphaferrocene-oxazoline-catalyzed cycloaddition reaction 
 
 
 
Later, Sibi and coworkers described an exo-dominant, enantioselective 1,3-dipolar 
cycloaddition reaction of azomethine imines with α,β-unsaturated pyrazolidinone 
imides. In the presence of a catalytic amount of Cu(OTf)2 and a chiral bis(oxazoline) 
ligand, 2-acryloyl-3-pyrazolidinones were formed in high yields with good ee.
[52]
 In 
this case, the Cu(II) complex afforded better results than the Ni(II) complex due to 
metal geometric difference (Scheme 49). 
 
Scheme 49 Bis(oxazoline) liganded Cu(II)-catalyzed [3+2] cycloaddition 
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Other successful examples of the [3+2] cycloaddition reaction between 
azomethine imines and substituted acroleins by aid of a titanium-BINOLate complex 
(90b in Scheme 45) were disclosed by Maruoka.
[53]
 Various substituted C,N-cyclic 
azomethine imines were well tolerated. α,β-Disubstituted unsaturated aldehydes 
showed high diastereomeric selectivities and enantioselectivities (Scheme 50). 
However, β-unsubstituted unsaturated aldehydes afforded almost equal amounts of 
the two diastereomers, propably owing to the steric factor.  
 
Scheme 50 Titanium-BINOLate complex-mediated [3+2] cycloaddition reaction 
 
 
 
1.1.3 Nitrile Imines as Substrates for Pyrazoles by [3+2] Cycloadditions 
 
Nitrile imines are well known 1,3-dipoles for the [3+2] cycloadditions with 
olefins for the synthesis of biological 4, 5-dihydropyrazole compounds. Although the 
inter- and intramolecular cycloaddition reactions of nitrile imines with olefins have 
been well established, however, only diastereoselective reactions are known. In this 
context, Sibi firstly reported a highly regio- and enantioselective cycloaddition 
reaction of nitrile imines with olefins which was catalyzed by chiral Mg(II) 
complexes
[54]
. Compared with some traditional Lewis acids such as Cu(OTf)2, 
Ni(ClO4)2 and Zn(NTf2)2, Mg(NTf2)2 afforded better results probably owing to the 
adverse interactions between those Lewis acids and either the 1,3-dipoles or the amine 
bases (Scheme 51). 
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Scheme 51 Mg/BOX-mediated cycloaddition of nitrile imines with olefins 
 
 
 
Kobayashi successfully reported chiral zirconium complex-catalyzed intra- and 
inter-molecular asymmetric [3+2] cycloaddition reactions of hydrazones with olefins, 
yielding optical active pyrazolidine and pyrazoline derivatives. Interestingly, addition 
of PrOH increased the yields and selectivities dramatically, giving the desired 
products with 96% ee in up to 99% yields under mild conditions. Notably, the 
chirality of the catalytic complex had a great influence on the cis/trans selectivities 
(Scheme 52).
[55]
 
 
Scheme 52 Zirconium complex-catalyzed asymmetric [3+2] cycloaddition reactions 
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1.1.4 Hydroxylamines and Hydrazines as Substrates for Pyrazoles by [3+2] 
Cycloadditions 
 
The bisnucleophilic donors such as hydroxylamines and hydrazines also have 
been applied as the substrates for the [3+2] cycloaddition reactions, affording 
heterocyclic adducts of potential pharmaceutical interests. As a clear differentiation of 
nucleophilicity between the two donor atoms, N-monosubstituted hydroxylamines and 
hydazines underwent the enantioselective reactions in good chemoselectivities. Thus, 
Sibi described a first example of the enantioselective and chemoselective 
cycloaddition reaction of monosubstituted hydrazines to α,β-unsaturated imides with a 
catalytic amount of a chiral Lewis acid.
[56]
 Monosubstituted hydrazines other than 
parent hydrazines were utilized for the latter ones could give amidation products 
(Scheme 53). 
 
Scheme 53 Mg(II)-mediated cycloaddition of monosubstituted hydrazines with 
oxazolidinone crotonates 
 
 
 
Very recently, Müller and List reported an alternative access to dihydropyrazolines 
by asymmetric 6π electrocyclization of α,β-unsaturated hydrazones in high yields and 
enantioselectivities, which was mediated by phosphoric acids.
[57]
 Under the existence 
of 3,3’-bis-(9-anthracenyl) substituted binol phosphate, α,β-unsaturated hydrazones 
cyclized smoothly at 30 
o
C in chlorobenzene in high yields (up to 99%) and 
enantioselectivities (up to 98:2 er). Interestingly, all kinds of halogen atoms, as well 
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as strongly electron-withdrawing substituents of the enones part and electron-donating 
substituents of the hydrazines part were well tolerated except for aliphatic group on 
the enones parts (Scheme 54). 
  
Scheme 54 6 electrocycloaddition of α,β-unsaturated hydrazones 
 
 
It is noteworthy that reports on the enantioselective synthesis of 
4,5-dihydropyrazoles with a polar group on N1 position of hydrazones are rare. Brière 
and coworkers developed a powerful domino aza- Michael 
addition/cyclocondensation strategy for the enantioselective synthesis of 3,5-diaryl 
dihydropyrazoles.
[58]
 In the presence of a quaternary ammonium salt, K3PO4 afforded 
higher ee than Cs2CO3. A virtually enantiopure pyrazoline 121a was obtained after 
recrystallization. The only drawback of the new methodology was that only the 
N-Boc hydrazines underwent the cycloaddition reaction (Scheme 55). 
 
Scheme 55 Synthesis of N1-Boc 4,5-dihydropyrazolines 
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These pioneering works stand out however, there are still some drawbacks that 
hinder the wide applications of these methods, such as unsatisfactory yields, poor 
chemo- and/or stereoselectivities, and limited substrate scope. Therefore, it is still 
highly desirable to develop a general strategy towards enantioenriched 
dihydropyrazole derivatives with functional diversity. 
 
1.1.5 Introduction of the Formal [4+1] Cycloaddition Reactions 
 
Initiated by Murai, the formal [4+1] cycloadditions of 1,3-conjugated systems, 
which act as four-atom assembling units, with two electrons, one-carbon synthons 
have proven as attractive strategies towards structurally diverse five-membered carbo- 
and heterocyclic compounds. As reported, the [4+1] cycloaddition of 1,3-dienes and 
carbon monoxide afforded an easy access to cyclopentenones. Thus, if replaced by a 
hetero-atom on the terminal carbon, five-membered heterocyclic compounds such as 
unsaturated γ-lactones or γ-lactams will be formed. Under the context, Murai reported 
first examples of [4+1] cycloadditions of structurally simple α,β-unsaturated imines 
with carbon monoxide, affording unsaturated γ-lactams in the presence of a catalytic 
amount of Ru3(CO)12. But high temperature and long reaction time were required for 
moderate to good yields (Scheme 56).
[59]
 
 
Scheme 56 Synthesis of cyclopentenones through the [4+1] cycloaddition 
 
 
 
After the pioneering exploration on the [4+1] cycloaddition reactions, numerous 
attempts were made for the synthesis of five-membered carbo- and heterocyclic 
compounds. For example, Chatani successively reported a [4+1] cycloaddition of 
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α,β-unsaturated carbonyl compounds with isocyanides affording γ-lactones 
derivatives, by aid of a catalytic amount of GaCl3.
[60]
 Barluenga applied the 
cycloaddition reaction on the Fischer carbene complexes with unsaturated ketones 
giving 2,3-dihydrofurans adducts.
[61]
 However, the research on the topic remains 
unexploited. 
 
1.1.6 Introduction of Sulfur Ylides 
 
Sulfur ylides are identified as versatile and valuable 1,1’-dipolar synthons that 
react with a variety of electron-deficient conjugated alkenes affording 
multi-functionalized carbo-/heterocyclic motifs. Therefore, sulfur ylides have been 
applied towards all kinds three-membered compounds such as epoxides, aziridines, 
and cyclopropanes.
[62]
 Initiated by Xiao, stable sulfur ylides were applied in 
axial-to-central chirality transfer [4+1] cycloaddition strategies to react with 
ester-bearing unsaturated imines and nitroolefins, giving access to some 
pharmaceutically and biologically useful five-membered hetero-compounds (Scheme 
57).
[63]
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Scheme 57 [4+1] Cycloaddition strategies of sulfur ylides for five-membered 
compounds 
 
 
2 Research Objective  
 
For the current report, it is also noteworthy that azoalkenes, which can be readily 
formed by a two-electron oxidation procedure from halo-N-sulfonyl hydrazones, are 
highly susceptible to conjugate addition to give the corresponding functionalized 
hydrazones (Scheme 58, eq. A).
[64]
 
In the light of all of those findings, we wondered about the possibility of formal 
asymmetric [4+1] cycloaddition of in situ-generated azoalkenes with sulfur ylides 
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providing optically active dihydropyrazoles under chiral Lewis acid catalysis (Scheme 
58, eq. B). In this scenario, several challenges had to be encountered: 1) the 
conditions for the generation of the reactive azoalkenes should not interfere with the 
following asymmetric cycloaddition; 2) the Lewis acids should preferentially 
coordinate with the azoalkenes over the sulfur ylides; 3) possible background 
reactions could be detrimental to the enantioselectivities. The methodological 
difficulties were mostly expressed by the lack of examples of catalytic asymmetric 
cycloadditions of sulfur ylides leading to five-membered carbo-/heterocyclic systems. 
Herein, we reported a successful introduction of such a strategy using a chiral copper 
complex for the catalytic asymmetric formal [4+1] cycloaddition, providing 
dihydropyrazoles with high enantioselectivities in good yields (Scheme 58, eq. B). 
 
Scheme 58 Research objective 
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3 Results and Discussions 
 
3.1 Screening on Metal Catalysts 
   
With N-benzoyl hydrazine 124d and sulfur ylide 125a as substrates and 
(R)-tol-BINAP as ligand for the model reaction, the activities of different transition 
metal salts were tested (Table 5). In general, Cu salts provided better yields and ee 
ratios than Zn(OTf)2, AgOTf and Mg(OTf)2 (entries 1-3). Among all the Cu(I) and 
Cu(II) salts, Cu(OTf)2 was the most active catalyst for the reaction, providing the 
highest yield (89%) and er (90:10) (entries 4-7). Surprisingly, when the reaction took 
place at -40 
o
C, the er ratio was lower, at 85:15 (entry 12). 
 
Table 5 Screening of metal catalysts
a
 
 
 
 
Entry Metal Temp. (
o
C) t (h) Yield (%) er (%)
b
 
1 Zn(OTf)2 r.t. 1 84 51:49 
2 AgOTf r.t. 1 71 0 
3 Mg(OTf)2 r.t. 16 73 2 
4 CuCl r.t. 1 83 75:25 
5 CuBr2 r.t. 2 84 73:27 
6 CuI r.t. 2 85 73:27 
7 CuI -20 16 84 89:11 
8 Cu(OTf)2 r.t. 2 80 77:23 
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9 Cu(OTf)2 -10 24 80 90:10 
10 Cu(OTf)2 -20 17 89 91:9 
11 Cu(OTf)2 -30 36 83 92:8 
12
c
 Cu(OTf)2 -40 48 86 85:15 
Notes:
 
[a] Conditions: 124d (0.3 mmol, 1.0 eq.), 125a (0.45 mmol, 1.5 eq.), 
metal/ligand (10 mol %), Na2CO3 (0.5 eq.), THF (10 mL) under Ar. [b] Determined 
by HPLC using a chiral stationary phase. [c] THF/CH2Cl2 (1:1) was used as solvent. 
 
3.2 Screening on Ligands 
 
Cu(OTf)2 was proven to be the best catalyst for the [4+1] cycloaddition reaction. 
Thus, the optimization studies were started using N-Boc hydrazone 124a and sulfur 
ylide 125a in the presence of the chiral complex, which was formed in situ from 
sulfoximine L1
 
and copper(II) triflate. To our delight, this combination showed good 
catalytic activity for the reaction, giving the product 126aa in 80% yield with an er 
ratio of 58:42 (Table 5, entry 1). The use of BINAP improved the er to 66:34 (entry 2). 
Another phosphine ligand L4 gave the best enantioselectivity. Some N-ligands or 
P,N-ligands were less active or ineffective (entries 4-11). The effects of changing R 
substituents at the hydrazone acyl group were examined. As a result, it slightly 
improved the enantioselectivities (entries 3-5). Notably, the er ratio of the product 
increased to 73:27 when benzoyl hydrazone 124d was employed (entry 14). By using 
this substrate, various ligands were investigated. Fortunately, use of (R)-tol-BINAP 
(L3) greatly improved the er ratio, up to 77:23 and 80% yield (entry 15). Finally, we 
found that 10 mol % of Cu(OTf)2, 11 mol % of ligand L3, and 1.0 equiv. of Na2CO3 
at -30 °C proved to be the most effective conditions. The product was obtained in 
83% yield with an er ratio of 92:8 (Table 5, entry 16).  
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Table 6 Optimization on ligands
a 
 
 
 Entry 124 Ligand Temp (
o
C) t (h) Yield (%) er
b
 
1 124a L1 r.t. 2 80 58:42 
2 124a L2 r.t. 2 90 66:34 
3 124a L3 r.t. 8 80 56:44 
4 124a L4 r.t. 2 81 71:29 
5 124a L5 r.t. 2 83 57:43 
6 124a L6 r.t. 1 77 57:43 
7 124a L7 r.t. 1 86 0 
8 124a L8 r.t. 1 86 0 
Chapter 2 
92 
 
9 124a L9 r.t. 1 85 0 
10 124a L10 r.t. 1 85 53:47 
11 124a L11 r.t. 1 78 51:49 
12 124b L2 r.t. 1 85 55:45 
13 124c L2 r.t. 1 72 55:45 
14 124d L2 r.t. 2 90 73:37 
15 124d L3 r.t. 2 80 77:23 
16
c
 124d L3 -20 17 89 91:9 
17
c
 124d L3 -30 36 83 92:8 
Notes: [a] Conditions: 124 (0.3 mmol, 1.0 eq.), 125a (0.45 mmol, 1.5 eq.), 
metal/ligand (10 mol %), Na2CO3 (0.5 eq.), THF (10 mL) under Ar. [b] 
Determined by HPLC using a chiral stationary phase. [c] Performed with 
1.0 eq. of Na2CO3 and 11 mol % of the ligand. 
 
 
3.3 Substrate Scope 
 
Under the optimized conditions, several sulfur ylides were tested with N-benzoyl 
hydrazone 124d. The results were summarized in Table 6. Thus, electron-poor and 
electron-rich sulfur ylides underwent the [4+1] cycloaddition reaction effectively with 
124d, affording corresponding cyclized products in high yields (85-95%, entries 2-6). 
The excellent er values were obtained (to 98:2) by recrystallization (entries 2 and 3). 
The best er ratio was 92:8 (entries 4 and 5). 4-Methoxy and 2-naphthyl sulfur ylides 
gave the adducts 126df and 126dg in good yields with good er ratios, respectively 
(entries 6 and 7). Except 124d, another N-benzoyl hydrazone 124e was also tested for 
the [4+1] cycloaddition reaction. The reaction the hydrazone 124e with phenyl sulfur 
ylide 125a, substantially afforded improved enantioselectivity (entry 8 vs entry 1, er 
ratios of 97:3 vs 91:9). Likewise, sulfur ylides having both electron-withdrawing and 
electron-donating groups at the para- and meta-positions of the phenyl ring reacted 
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well with 124e to provide the corresponding dihydropyrazoles in good yields and 
better enantioselectivities (with er values ranging from 92:8 to 97:3) (entries 8-17). 
The scope of this method was further extended to ylides bearing heterocycles. For 
example, 2-furyl sulfur ylide 125k and 2-thienyl sulfur ylide 125l reacted with 124e 
affording products 126ek and 126el with er values of 93:7 and 94:6, respectively 
(entries 18 and 19). 
 
Table 7 Substrtate scope on sulfur ylides
a
 
 
 
 
Entry 124 R
2
 Yield er
b
 
1  
 
126da R
2
 = H 89 91:9 
2 126db R
2
 = 4-BrC6H4 89(80) 91:9 (92:8)
c
 
3 126dc R
2
 = 4-ClC6H4 85(76) 90:10 (98:2)
c
 
4 126dd R
2
 = 3-NO2C6H4 92 92:8 
5 126de R
2
 = 4-CNC6H4 87 92:8 
6 126df R
2
 = 4-MeOC6H4 95 90:10 
7 126dg R
2
 = 2-Naphthyl 81 90:10 
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8
e
  
 
126ea R
2
 = H 84 97:3 
9 126eb R
2
 = 4-BrC6H4 84 97:3 
10 126ec R
2
 = 4-ClC6H4 93 96:4 
11
e
 126ed R
2
 = 3-NO2C6H4 84 92:8 
12 126ee R
2
 = 4-CNC6H4 88 94:6 
13 126ef R
2
 = 4-MeOC6H4 95 92:8 
14 126eg R
2
 = 2-Naphthyl 92 95:5 
15 126eh R
2
 = 4-FC6H4 93 96:4 
16
d
 126ei R
2
 = 3,4-Cl2C6H3 94 92:8 
17
d
 126ej R
2
 = 4-MeC6H4 92 95:5 
18 126ek R
2
 = 2-furyl 85 93:7 
19 126el R
2
 = 2-thienyl 88 94:6 
Notes: [a] Conditions: 124d or 124e (0.3 mmol, 1.0 eq.), 125 (0.45 mmol, 1.5 eq.), 
Cu(OTf)2 (10 mol %), (R)-tol-BINAP (11 mol %), Na2CO3 (1.0 eq.), and THF (10 
mL) under Ar at -20 
o
C. [b] Determined by HPLC using a chiral stationary phase. [c] 
Values in parentheses are the results after single recrystallizations. [d] With 2.0 eq. of 
the sulfur ylide. [e] Performed at -30 
o
C. 
 
The relationship between the absolute configurations of the ligand and a product 
was unambiguously determined by X-ray single crystal structure analysis of product 
(S)-185db (Figure 6) stemming from a copper catalysis with (R)-tol-BINAP as ligand. 
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Fugure 6 ORTEP diagram of the X-day data of 126db (CCDC No. 859661) 
 
The scope of the present copper-catalyzed asymmetric formal [4+1] cycloaddition 
was further extended to other hydrazones with phenyl sulfur ylide 125a (Table 8). 
Under the standard reaction conditions, hydrazones 124f-124h bearing Cl, F, and Me 
in the para-position of aryl ring, reacted with phenyl sulfur ylide 125a, affording the 
corresponding products in 94-97% yields with er values of up to 91:9 (entries 1-3). In 
a similar pattern, methoxybenzoyl hydrazones 124i-124m reacted smoothly with 125a 
affording the corresponding products in up to 96% yields and er values of up to 94:6 
(entries 4-8). In addition, aliphatic substituted hydrazones 124n-124s were employed, 
giving good to excellent yields and er ratios (entries 9-14). Interestingly, meta- or 
para-substituented hydrazones 124t-124v also reacted nicely with 125a, providing the 
products in high yields and with good enantioselectivities (entries 15-17).  
 
 
 
 
 
 
 
 
 
 
Chapter 2 
96 
 
Table 8 Substrate scope on hydrazones
a
 
 
 
Entry X 124 R
2
 Yield er
b
 
1 Cl 
 
126fa R
2
 = 4-ClC6H4 94 91:9 
2 Cl 126ga R
2
 = 4-FC6H4 97 90:10 
3 Br 126ha R
2
 = 4-MeC6H4 95 90:10 
4 Cl  
 
 
 
 
126ia R
2
 = 2,4-Cl2C6H3 84 93:7 
5 Cl 126ja R
2
 = 4-FC6H4 92 94:6 
6 Br 126ka R
2
 = 4-BrC6H4 88 88:12 
7 Cl 126la R
2
 = 4-ClC6H4 96 88:12 
8 Br 126ma R
2 
= 4-MeOC6H4 86 92:8 
9 Cl 126na R
2
 = Me 90 77:23 
10 Cl 126oa R
2
 = t-Bu 93 79:21 
11 Br 126pa R
2
 = i-Bu 84 87:13 
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12 Cl 126qa R
2
 = PhCH2CH2 93 87:13 
13 Br 126ra R
2
 = COOEt 93 93:7 
14 Cl 126sa R
2
 = PhCH=CH 91 71:29 
15 Cl 
 
126ta 83 92:8 
16 Cl 
 
126ua 88 91:9 
17 Br 
 
126va 97 90:10 
Notes: [a] Conditions: 124 (0.3 mmol, 1.0 eq.), 125a (0.45 mmol, 1.5 eq.), Cu(OTf)2 
(10 mol %), (R)-tol-BINAP (11 mol %), Na2CO3 (1.0 eq.), and THF (10 mL) under Ar 
at -20 
o
C. [b] Determined by HPLC using a chiral stationary phase. 
 
To demonstrate the synthetic potential of the method, the reaction of hydrazone 
124e and sulfur ylide 125a was carried out on a gram scale (Scheme 59). To our 
delight, the catalyst loading could be reduced to 5 mol % of the copper salt combined 
with 6 mol % of ligand L3, and the corresponding product (126ea) was isolated in 
92% yield with an er ratio of 96:4. 
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Scheme 59 Scale-up reaction 
 
 
 
4 Summary 
 
In summary, we developed a copper-catalyzed asymmetric formal [4+1] 
cycloaddition reaction of in situ-generated azoalkenes with sulfur ylides. It provided 
an efficient, enantioselective access to a variety of optically active dihydropyrazoles.  
 
5 Experimental Part 
 
The metal catalyst Cu(OTf)2 (10 mol %) and (R)-tol-BINAP L3 (11 mol %) were 
stirred in 10.0 mL of THF at room temperature for 1 h in a 50 mL schlenk tube under 
Ar. Then, the mixture was placed at -20 
o
C cooling bath and stirred for 20 minutes. 
Hydrazone 124 (0.30 mmol) and Na2CO3 (0.30 mmol) were added and the reaction 
mixture was stirred for additional 20 miniutes. Then, sulfur ylide 125 (0.45 mmol) 
was added quickly to the mixture. Upon the completion of the reaction (by TLC), the 
reaction was quenched by saturated NH4Cl solution (5 mL) and then extracted with 
EtOAc (3 × 10 mL). The combined organic layers were dried over MgSO4. After 
removal of the solvent, the residue was purified directly by flash column 
chromatography on silica gel (pentane/ethyl acetate (3:1 to 1.5:1) as eluent) to give 
the corresponding cyclized product 126 as white solid. 
 
 
Chapter 2 
99 
 
6 Data and Characterization 
 
(5S)-1-tert-Butyl carboxylic acid ester-3-phenyl-5-benzoyl-4,5-dihydro pyrazole 
(126aa) 
 
Yield: 80%. Melting point: 123.2‐124.1 oC.  
The er was determined by HPLC (Chiralpak AD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 16.1 min; tR (major) = 25.5 min, er 
= 66:34.  
1
H NMR (400 MHz, CDCl3)  = 7.91 (d, J = 7.6 Hz, 2H), 7.64 (s, 2H), 7.54 (t, J = 7.3 
Hz, 1H), 7.43 (t, J = 7.6 Hz, 2H), 7.34 – 7.23 (m, 3H), 5.61 (s, 1H), 3.62 (t, J = 15.0 
Hz, 1H), 3.15 (s, 1H), 1.36 (s, 9H) (ppm).  
13
C NMR (100 MHz, CDCl3)  = 195.0, 151.5, 133.9, 133.8, 130.9, 130.0, 128.9, 
128.5, 128.4, 126.6, 81.9, 62.1, 38.2, 28.0 (ppm).  
MS (EI): m/z = 350 (M
+
). 
IR (KBr): 2975, 1731, 1694, 1398, 1254, 1146, 756, 689 (cm
-1
).  
Anal. calcd for (C21H22N2O3): C, 71.98; H, 6.33; N, 7.99. Found: C, 71.93; H, 6.18; N, 
7.99. 
 
(5S)-1-Ethyl carboxylic acid ester-3-phenyl-5-benzoyl-4,5-dihydro pyrazole (126ba) 
 
Yield: 85%. Melting point: 119.4-120.6 
o
C. 
The er was determined by HPLC (Chiralpak AD column, heptane/i-PrOH 6:4, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (major) = 24.6 min; tR (minor) = 39.9 min, er 
=55:45.  
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1
H NMR (300 MHz, CDCl3)  = 8.01 (d, J = 7.3 Hz, 2H), 7.73– 7.70 (m, 2H), 7.63 (t, 
J = 7.4 Hz, 1H), 7.51 (t, J = 7.5 Hz, 2H), 7.38 – 7.33 (m, 3H), 5.82 (d, J = 6.8 Hz, 1H), 
4.29 (s, 2H), 3.72 (dd, J = 17.4, 12.9 Hz, 1H), 3.22 (dd, J = 17.4, 6.0 Hz, 1H), 1.33 (s, 
3H) (ppm).  
13
C NMR (100 MHz, CDCl3)  = 194.3, 152.3, 133.8, 130.7, 130.2, 128.9, 128.6, 
128.5, 126.6, 62.5, 61.2, 37.6, 14.5 (ppm).  
MS (EI): m/z = 322 (M
+
). 
IR (KBr): 2987, 1716, 1691, 1417, 1264, 1177, 1132, 1017, 758, 689 (cm
-1
).  
Anal. calcd for (C19H18N2O3): C, 70.79; H, 5.63; N, 8.69. Found: C, 70.80; H, 5.45; N, 
8.67. 
 
(5S)-1-Methyl carboxylic acid ester-3-phenyl-5-benzoyl-4,5-dihydro pyrazole (126ca) 
 
Yield: 72%. Melting point: 136.5-138.0 
o
C. 
The er was determined by HPLC (Chiralpak AD column, heptane/i-PrOH 6:4, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (major) = 25.5 min; tR (minor) = 37.7 min, er 
= 55:45.  
1
H NMR (400 MHz, CDCl3)  = 8.02 (d, J = 7.5 Hz, 2H), 7.72 (dd, J = 7.4, 1.8 Hz, 
2H), 7.64 (t, J = 7.4 Hz, 1H), 7.53 (t, J = 7.7 Hz, 2H), 7.40 – 7.36 (m, 3H), 5.84 (s, 
1H), 3.89 (s, 3H), 3.74 (dd, J = 17.3, 13.0 Hz, 1H), 3.25 (dd, J = 17.4, 6.0 Hz, 1H) 
(ppm).  
13
C NMR (150 MHz, CDCl3)  = 194.1, 153.4, 152.6, 133.9, 133.7, 130.6, 130.3, 
128.9, 128.7, 128.5, 126.6, 61.0, 53.6, 37.6 (ppm).  
MS (EI): m/z = 308 (M
+
). 
IR (KBr): 2957, 1676, 1463, 1407, 1333, 1158, 869, 756, 694 (cm
-1
). 
Anal. calcd for (C18H16N2O3): C, 70.12; H, 5.23; N, 9.09. Found: C, 69.77; H, 5.14; N, 
8.89. 
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(5S)-1,5-Dibenzoyl -3-phenyl-4,5-dihydro pyrazole (126da) 
 
Yield: 83%. Melting point: 177.4-178.0 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 14.1 min; tR (major) = 19.0 min, ee 
= 92:8.  
1
H NMR (400 MHz, CDCl3)  = 8.09 (d, J = 7.3 Hz, 4H), 7.69 – 7.62 (m, 3H), 7.55 – 
7.44 (m, 5H), 7.42 – 7.36 (m, 3H), 6.17 (dd, J = 12.5, 6.3 Hz, 1H), 3.70 (dd, J = 17.4, 
12.5 Hz, 1H), 3.25 (dd, J = 17.4, 6.3 Hz, 1H) (ppm).  
13
C NMR (150 MHz, CDCl3)  = 194.2, 166.0, 154.1, 134.2, 133.9, 133.5, 131.2, 
130.8, 130.5, 130.1, 128.9, 128.8, 128.7, 127.7, 126.6, 60.9, 36.6 (ppm).  
MS (EI): m/z = 354 (M
+
). 
IR (KBr): 3056, 1689, 1603, 1564, 1448, 1426, 1336, 761, 697 (cm
-1
). 
Anal. calcd for (C23H18N2O2): C, 77.95; H, 5.12; N, 7.90. Found: C, 77.90; H, 5.18; N, 
7.79. 
 
(5S)-1-Benzoyl-3-phenyl-5-(para-bromobenzoyl)-4,5-dihydro pyrazole (126db) 
 
Yield: 89%. Melting point: 203.3-204.0 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 15.7 min; tR (major) = 28.5 min, ee 
= 98:2.  
1
H NMR (400 MHz, CDCl3)  = 8.08 (dd, J = 8.3, 1.3 Hz, 2H), 7.96 (d, J = 8.6 Hz, 
2H), 7.68 (d, J = 8.4 Hz, 4H), 7.54 – 7.37 (m, 6H), 6.10 (dd, J = 12.4, 6.4 Hz, 1H), 
3.68 (dd, J = 17.4, 12.5 Hz, 1H), 3.24 (dd, J = 17.4, 6.4 Hz, 1H) (ppm).  
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13
C NMR (100 MHz, CDCl3)  = 193.8, 166.3, 153.9, 133.4, 133.4, 133.2, 132.2, 
131.3, 130.8, 130.6, 130.3, 130.2, 129.2, 128.7, 127.7, 126.7, 60.7, 36.6 (ppm).  
MS (EI): m/z = 433 (M
+
+1). 
IR (KBr): 3054, 1688, 1604, 1562, 1423, 1334, 822, 703, 681 (cm
-1
).  
Anal. calcd for (C23H17BrN2O2): C, 63.75; H, 3.95; N, 6.47. Found: C, 64.10; H, 4.17; 
N, 6.15. 
 
(5S)-1-Benzoyl-3-phenyl-5-(para-chlorobenzoyl)-4,5-dihydro pyrazole (126dc) 
 
Yield: 85%. Melting point: 190.8-191.9 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 13.4 min; tR (major) = 24.8 min, ee 
= 98:2.  
1
H NMR (600 MHz, CDCl3)  = 8.07 (d, J = 7.4 Hz, 2H), 8.03 (d, J = 8.4 Hz, 2H), 
7.67 (d, J = 6.9 Hz, 2H), 7.57 – 7.31 (m, 8H), 6.10 (dd, J = 12.4, 6.4 Hz, 1H), 3.67 
(dd, J = 17.3, 12.5 Hz, 1H), 3.23 (dd, J = 17.3, 6.4 Hz, 1H) (ppm).  
13
C NMR (150 MHz, CDCl3)  = 193.6, 166.3, 153.9, 140.4, 133.2, 132.9, 131.3, 
130.8, 130.5, 130.2, 129.2, 128.7, 127.7, 126.7, 60.7, 36.6 (ppm).  
MS (EI): m/z = 388 (M
+
). 
IR (KBr): 3054, 1689, 1606, 1563, 1424, 1335, 1224, 822, 682 (cm
-1
).  
Anal. calcd for (C23H17ClN2O2): C, 71.04; H, 4.41; N, 7.20. Found: C, 71.06; H, 4.31; 
N, 7.05. 
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(5S)-1-Benzoyl-3-phenyl-5-(meta-nitrobenzoyl)-4,5-dihydro pyrazole (126dd) 
 
Yield: 92%. Melting point: 203.5-204.5 
o
C.  
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 6:4, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 20.4 min; tR (major) = 34.5 min, er 
= 92:8.  
1
H NMR (300 MHz, CDCl3)  = 8.91 (t, J = 1.9 Hz, 1H), 8.48 – 8.46 (m, 1H), 8.45 – 
8.42 (m, 1H), 8.07 (dd, J = 8.3, 1.4 Hz, 2H), 7.74 – 7.68 (m, 3H), 7.56 – 7.39 (m, 6H), 
6.14 (dd, J = 12.3, 6.7 Hz, 1H), 3.74 (dd, J = 17.4, 12.3 Hz, 1H), 3.30 (dd, J = 17.4, 
6.7 Hz, 1H) (ppm).  
13
C NMR (101 MHz, CDCl3)  193.4, 166.2, 154.2, 148.5, 136.2, 134.3, 132.8, 
131.5, 130.7, 130.6, 130.2, 130.2, 128.8, 128.0, 127.8, 126.8, 123.5, 60.7, 36.5 (ppm).  
MS (EI): m/z = 399 (M
+
). 
IR (KBr): 3055, 1700, 1625, 1525, 1431, 1338, 1214, 769, 699 (cm
-1
).  
Anal. calcd for (C23H17N3O4): C, 69.17; H, 4.29; N, 10.52. Found: C, 69.20; H, 4.31; 
N, 10.59. 
 
(5S)-1-Benzoyl-3-phenyl-5-(para-nitrilbenzoyl)-4,5-dihydro pyrazole (126de) 
 
Yield: 87%. Melting point: 235.0-235.8 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 6:4, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 19.9 min; tR (major) = 45.3 min, er 
= 92:8.  
1
H NMR (400 MHz, CDCl3)  8.18 (d, J = 8.5 Hz, 2H), 8.07 (dd, J = 8.4, 1.3 Hz, 
2H), 7.83 (d, J = 8.6 Hz, 2H), 7.69 (dd, J = 7.8, 1.7 Hz, 2H), 7.53 – 7.39 (m, 6H), 6.09 
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(dd, J = 12.3, 6.7 Hz, 1H), 3.69 (dd, J = 17.4, 12.4 Hz, 1H), 3.27 (dd, J = 17.4, 6.7 Hz, 
1H) (ppm).  
13
C NMR (100 MHz, CDCl3)  = 194.3, 166.3, 154.1, 138.1, 132.9, 132.7, 131.5, 
130.8, 130.6, 130.2, 129.1, 128.8, 127.8, 126.8, 117.8, 117.0, 60.8, 36.5 (ppm). 
MS (EI): m/z = 379 (M
+
). 
IR (KBr): 3053, 1696, 1604, 1561, 1419, 1335, 823, 702 (cm
-1
).  
Anal. calcd for (C24H17N3O2): C, 75.97; H, 4.52; N, 11.08. Found: C, 75.81; H, 4.44; 
N, 11.06. 
 
(5S)-1-Benzoyl-3-phenyl-5-(meta-methoxybenzoyl)-4,5-dihydro pyrazole (126df) 
 
Yield: 95%. Melting point: 154.9-155.8 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 17.8 min; tR (major) = 23.2 min, er 
= 90:10.  
1
H NMR (300 MHz, CDCl3)  = 8.08 (dd, J = 8.1, 1.6 Hz, 2H), 7.65 – 7.57 (m, 4H), 
7.52 – 7.30 (m, 7H), 7.16 – 7.12 (m, 1H), 6.10 (dd, J = 12.6, 6.3 Hz, 1H), 3.82 (s, 3H), 
3.64 (dd, J = 17.5, 12.6 Hz, 1H), 3.19 (dd, J = 17.5, 6.3 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 193.9, 166.1, 159.9, 153.8, 135.6, 133.4, 131.1, 130.8, 
130.3, 130.1, 129.8, 128.6, 127.6, 126.6, 121.2, 120.4, 112.9, 61.0, 55.4, 36.6 (ppm). 
MS (EI): m/z = 384 (M
+
). 
IR (KBr): 3066, 1691, 1619, 1450, 1425, 1331, 1259, 1030, 762, 689 (cm
-1
).  
Anal. calcd for (C24H20N2O3): C, 74.98; H, 5.24; N, 7.29. Found: C, 73.90; H, 5.39; N, 
7.29. 
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(5S)-1-Benzoyl-3-phenyl-5-(2-naphthalenylcarbonyl)-4,5-dihydro pyrazole (126dg) 
 
Yield: 81%. Melting point: 178.5-179.5 
o
C.  
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (major) = 26.8 min; tR (minor) = 43.8 min, er 
= 90:10.  
1
H NMR (400 MHz, CDCl3)  = 8.60 (s, 1H), 8.11 – 8.06 (m, 3H), 7.95 (d, J = 8.0 Hz, 
1H), 7.88 (d, J = 8.6 Hz, 1H), 7.84 (d, J = 8.1 Hz, 1H), 7.63 (dd, J = 7.8, 1.7 Hz, 2H), 
7.61 – 7.30 (m, 8H), 6.30 (dd, J = 12.5, 6.3 Hz, 1H), 3.69 (dd, J = 17.5, 12.6 Hz, 1H), 
3.24 (dd, J = 17.5, 6.3 Hz, 1H) (ppm).  
13
C NMR (100 MHz, CDCl3)  194.3, 166.2, 154.0, 135.8, 133.5, 132.4, 131.7, 
131.1, 130.8, 130.7, 130.4, 130.2, 129.6, 128.8, 128.8, 128.6, 127.7, 127.6, 126.9, 
126.6, 124.1, 60.9, 36.7 (ppm).  
MS (EI): m/z = 404 (M
+
). 
IR (KBr): 3052, 1687, 1609, 1566, 1449, 1424, 1180, 756, 694 (cm
-1
).  
Anal. calcd for (C27H20N2O2): C, 80.18; H, 4.98; N, 6.93. Found: C, 80.21; H, 4.92; N, 
6.60. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(meta-methoxybenzoyl)-4,5-dihydro 
pyrazole (126ea) 
 
Yield: 84%. Melting point: 156.0-156.8 
o
C.  
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 16.9 min; tR (major) = 26.7 min, er 
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= 97:3.  
1
H NMR (300 MHz, CDCl3)  8.08 (t, J = 1.3 Hz, 1H), 8.06 (t, J = 1.7 Hz, 1H), 
7.69 – 7.58 (m, 1H), 7.58 – 7.47 (m, 5H), 7.44 – 7.37 (m, 1H), 7.31 – 7.29 (m, 3H), 
7.04 – 6.95 (m, 2H), 6.12 (dd, J = 12.6, 6.0 Hz, 1H), 3.83 (s, 3H), 3.70 (dd, J = 17.5, 
12.6 Hz, 1H), 3.22 (dd, J = 17.5, 6.0 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.0, 166.2, 156.7, 153.2, 134.3, 133.7, 130.9, 130.9, 
130.2, 129.4, 128.8, 128.8, 128.5, 126.5, 125.0, 120.1, 111.2, 60.3, 55.8, 37.2 (ppm). 
MS (EI): m/z = 384 (M
+
). 
IR (KBr): 2968, 1697, 1631, 1594, 1458, 1431, 1224, 758, 693 (cm
-1
).  
Anal. calcd for (C24H20N2O3): C, 74.98; H, 5.24; N, 7.29. Found: C, 75.38; H, 5.07; N, 
7.12. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(para-bromobenzoyl)-4,5-dihydro 
pyrazole (126eb) 
 
Yield: 91%. Melting point: 113.8-114.5 
o
C.  
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 19.3 min; tR (major) = 50.5 min, er 
= 97:3.  
1
H NMR (600 MHz, CDCl3)  = 7.94 (d, J = 8.3 Hz, 2H), 7.63 (d, J = 8.3 Hz, 2H), 
7.54 (d, J = 7.4 Hz, 2H), 7.49 (d, J = 7.3 Hz, 1H), 7.41 (t, J = 7.8 Hz, 1H), 7.33 (m, 
3H), 7.01 (t, J = 7.4 Hz, 1H), 6.97 (d, J = 8.3 Hz, 1H), 6.05 (dd, J = 12.5, 6.1 Hz, 1H), 
3.82 (s, 3H), 3.69 (dd, J = 17.3, 12.7 Hz, 1H), 3.22 (dd, J = 17.4, 6.0 Hz, 1H) (ppm). 
13
C NMR (150 MHz, CDCl3)  = 193.6, 166.3, 156.8, 153.3, 133.2, 132.1, 131.0, 
130.8, 130.3, 129.4, 129.1, 128.5, 126.6, 124.8, 120.1, 111.2, 60.2, 55.8, 37.2 (ppm).  
MS (EI): m/z = 462 (M
+
). 
IR (KBr): 2836, 1696, 1638, 1583, 1425, 1336, 1005, 833, 753, 690 (cm
-1
).  
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Anal. calcd for (C24H19BrN2O3): C, 62.22; H, 4.13; N, 6.05. Found: C, 62.00; H, 4.08; 
N, 5.89. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(meta-chlorobenzoyl)-4,5-dihydro 
pyrazole (126ec) 
 
Yield: 93%. Melting point: 119.0-120.0 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 6:4, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 13.0 min; tR (major) = 32.3 min, er 
= 96:4.  
1
H NMR (600 MHz, CDCl3) δ = 8.02 (d, J = 8.5 Hz, 2H), 7.55 (d, J = 7.2 Hz, 2H), 
7.48 (t, J = 9.0 Hz, 3H), 7.43 – 7.40 (m, 1H), 7.36 (t, J = 7.2 Hz, 1H), 7.32 (t, J = 7.4 
Hz, 2H), 7.02 (t, J = 7.4 Hz, 1H), 6.97 (d, J = 8.3 Hz, 1H), 6.06 (dd, J = 12.5, 6.1 Hz, 
1H), 3.83 (s, 3H), 3.69 (dd, J = 17.3, 12.6 Hz, 1H), 3.23 (dd, J = 17.4, 6.2 Hz, 1H) 
(ppm).  
13
C NMR (150 MHz, CDCl3)  = 193.4, 166.3, 156.8, 153.3, 140.3, 132.8, 131.0, 
130.9, 130.3, 130.3, 129.5, 129.1, 128.6, 126.6, 124.8, 120.1, 111.2, 60.2, 55.9, 37.2 
(ppm).  
MS (EI): m/z = 418 (M
+
). 
IR (KBr): 2325, 1695, 1639, 1588, 1425, 1222, 1009, 835, 753, 690 cm
-1
.  
Anal. Calcd for (C24H19ClN2O3): C, 68.82; H, 4.57; N, 6.69. Found: C, 68.64; H, 4.57; 
N, 6.55. 
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(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(meta-nitrobenzoyl)-4,5-dihydro pyrazole 
(126ed) 
 
Yield: 84%. Melting point: 121.5-122.8 
o
C. 
The er ratio was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, 
flow rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 21.6 min; tR (major) = 53.8 
min, er = 92:8.  
1
H NMR (300 MHz, CDCl3)  = 8.90 (s, 1H), 8.44 (t, J = 8.1 Hz, 2H), 7.72 (t, J = 8.0 
Hz, 1H), 7.57 (dd, J = 7.7, 1.4 Hz, 2H), 7.48 – 7.29 (m, 5H), 7.00 (dd, J = 15.8, 8.0 
Hz, 2H), 6.10 (dd, J = 12.4, 6.5 Hz, 1H), 3.83 (s, 3H), 3.80 – 3.67 (m, 1H), 3.30 (dd, J 
= 17.4, 6.4 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3) 193.2, 166.3, 156.8, 153.5, 148.4, 136.1, 134.4, 131.3, 
130.7, 130.5, 130.1, 129.4, 128.6, 127.8, 126.6, 124.4, 123.5, 120.1, 111.3, 60.1, 55.8, 
37.1 (ppm).  
MS (EI): m/z = 279.3 (78), 409.2 (100), 429.5 (6, M
+
). 
IR (KBr): 3081, 1702, 1637, 1530, 1462, 1427, 1343, 1249, 1222, 1018, 756, 711 
(cm
-1
).  
Anal. calcd for (C24H19N3O5): C, 67.13; H, 4.46; N, 9.79. Found: C, 66.82; H, 4.44; N, 
9.68. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(para-nitrilbenzoyl)-4,5-dihydro pyrazole 
(126ee) 
 
Yield: 88%. Melting point: 121.0-122.5 
o
C.  
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The er ratio was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, 
flow rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 20.9 min; tR (major) = 78.2 
min, er = 94:6.  
1
H NMR (300 MHz, CDCl3)  = 8.16 (d, J = 8.3 Hz, 2H), 7.79 (d, J = 8.3 Hz, 2H), 
7.56 (dd, J = 7.8, 1.4 Hz, 2H), 7.47 – 7.30 (m, 5H), 7.01 (dd, J = 15.8, 8.0 Hz, 2H), 
6.04 (dd, J = 12.4, 6.5 Hz, 1H), 3.83 (s, 3H), 3.71 (dd, J = 17.4, 12.4 Hz, 1H), 3.26 
(dd, J = 17.4, 6.5 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.1, 166.3, 156.8, 153.5, 137.9, 132.6, 131.3, 130.7, 
130.5, 129.4, 129.2, 128.6, 126.6, 124.4, 120.2, 117.8, 116.8, 111.3, 60.3, 55.8, 37.1 
(ppm).  
MS (EI): m/z = 278.6 (61), 409.2 (100, M
+
).  
IR (KBr): 2940, 1700, 1636, 1600, 1427, 1247, 1223, 1015, 840, 755, 691 (cm
-1
).  
Anal. calcd for (C25H19N3O3): C, 73.34; H, 4.68; N, 10.26. Found: C, 73.00; H, 4.89; 
N, 10.05. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(meta-methoxybenzoyl)-4,5-dihydro 
pyrazole (126ef) 
 
Yield: 95%. (liquid) 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 17.3 min; tR (major) = 21.2 min, er 
= 92:8.  
1
H NMR (400 MHz, CDCl3)  = 7.66 – 7.63 (m, 1H), 7.60 (dd, J = 2.5, 1.6 Hz, 1H), 
7.56 – 7.49 (m, 3H), 7.44 – 7.39 (m, 2H), 7.32 ‐7.30 (m, 3H), 7.17 – 7.15 (m, 1H), 
7.04 – 7.00 (m, 1H), 6.97 (d, J = 8.3 Hz, 1H), 6.10 (dd, J = 12.6, 6.0 Hz, 1H), 3.85 (s, 
3H), 3.84 (s, 3H), 3.71 (dd, J = 17.5, 12.7 Hz, 1H), 3.24 (dd, J = 17.5, 6.0 Hz, 1H). 
13
C NMR (100 MHz, CDCl3)  = 193.8, 166.3, 160.0, 156.8, 153.2, 135.6, 131.0, 
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130.9, 130.2, 129.7, 129.5, 128.5, 126.5, 125.1, 121.3, 120.5, 120.1, 113.0, 111.2, 
60.5, 55.9, 55.4, 37.3 (ppm).  
MS (EI): m/z = 279.2 (45), 414.2 (100, M
+
). 
IR (KBr): 2938, 1639, 1593, 1488, 1459, 1426, 1253, 1020, 755 (cm
-1
).  
Anal. calcd for (C25H22N2O4): C, 72.45; H, 5.35; N, 6.76. Found: C, 71.84; H, 5.41; N, 
6.68. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(2-naphthalenylcarbonyl)-4,5-dihydro 
pyrazole (126eg) 
 
Yield: 92%. Melting point: 122.0-123.4 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (major) = 27.7 min; tR (minor) = 33.0 min, er 
= 95:5.  
1
H NMR (600 MHz, CDCl3)  = 8.63 (s, 1H), 8.11 (d, J = 8.5 Hz, 1H), 7.98 (d, J = 
8.1 Hz, 1H), 7.93 (d, J = 8.6 Hz, 1H), 7.88 (d, J = 8.1 Hz, 1H), 7.62 (t, J = 7.4 Hz, 
1H), 7.58 – 7.54 (m, 4H), 7.43 – 7.40 (m, 1H), 7.36 – 7.30 (m, 3H), 7.03 (t, J = 7.4 Hz, 
1H), 6.98 (d, J = 8.3 Hz, 1H), 6.31 (dd, J = 12.6, 5.9 Hz, 1H), 3.84 (s, 3H), 3.77 (dd, J 
= 17.4, 12.7 Hz, 1H), 3.30 (dd, J = 17.4, 5.9 Hz, 1H) (ppm).  
13
C NMR (150 MHz, CDCl3)  = 194.1, 166.3, 156.8, 153.3, 135.8, 132.4, 131.8, 
131.1, 130.9, 130.8, 130.2, 129.7, 129.5, 128.8, 128.8, 128.5, 127.8, 126.9, 126.6, 
125.1, 124.3, 120.1, 111.3, 60.3, 55.9, 37.5 (ppm).  
MS (EI): m/z = 269.9 (81), 278.2 (94), 434.3 (100, M
+
). 
IR (KBr): 3057, 1687, 1637, 1597, 1462, 1427, 1248, 755, 692 (cm
-1
).  
HRMS (EI): m/z calcd for C28H23N2O3 : 435.1703 [M+H]
+
; found: 435.1702. 
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(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(para-fluorobenzoyl)-4,5-dihydro 
pyrazole (126eh) 
 
Yield: 93%. Melting point: 120.0-120.9 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 6:4, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 11.2 min; tR (major) = 26.7 min, er 
= 96:4.  
1
H NMR (600 MHz, CDCl3)  = 8.12 (dd, J = 8.6, 5.4 Hz, 2H), 7.55 (d, J = 7.1 Hz, 
2H), 7.50 (dd, J = 7.4, 1.3 Hz, 1H), 7.43 – 7.40 (m, 1H), 7.36 – 7.30 (m, 3H), 7.17 (t, 
J = 8.5 Hz, 2H), 7.02 (t, J = 7.4 Hz, 1H), 6.97 (d, J = 8.3 Hz, 1H), 6.08 (dd, J = 12.6, 
6.1 Hz, 1H), 3.83 (s, 3H), 3.70 (dd, J = 17.4, 12.6 Hz, 1H), 3.23 (dd, J = 17.4, 6.1 Hz, 
1H) (ppm).  
13
C NMR (150 MHz, CDCl3)  = 192.9, 166.9, 166.3, 165.2, 156.8, 153.3, 131.6, 
131.5, 131.0, 130.9, 130.3, 129.4, 128.5, 126.6, 124.9, 120.1, 116.1, 115.9, 111.2, 60.1, 
55.8, 37.2 (ppm).  
MS (EI): m/z = 278.3 (95), 402.0 (100, M
+
). 
IR (KBr): 2933, 1696, 1637, 1595, 1423, 1225, 1155, 1017, 842, 754, 691 (cm
-1
).  
Anal. calcd for (C24H19FN2O3): C, 71.63; H, 4.76; N, 6.96. Found: C, 71.41; H, 4.77; 
N, 6.86. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(3,4-dichlorobenzoyl)-4,5-dihydro 
pyrazole (126ei) 
 
Yield: 94%. Melting point: 163.0-164.1 
o
C. 
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The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 6:4, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 14.9 min; tR (major) = 41.2 min, er 
= 92:8. 
1
H NMR (600 MHz, CDCl3)  = 8.16 (d, J = 1.7 Hz, 1H), 7.91 (dd, J = 8.3, 1.8 Hz, 
1H), 7.58 – 7.54 (m, 3H), 7.48 (d, J = 7.5 Hz, 1H), 7.43 – 7.40 (m, 1H), 7.38 – 7.31 
(m, 3H), 7.01 (t, J = 7.4 Hz, 1H), 6.97 (d, J = 8.3 Hz, 1H), 6.01 (dd, J = 12.5, 6.3 Hz, 
1H), 3.82 (s, 3H), 3.69 (dd, J = 17.3, 12.5 Hz, 1H), 3.23 (dd, J = 17.4, 6.3 Hz, 1H). 
13
C NMR (150 MHz, CDCl3)  = 192.8, 166.3, 156.8, 153.4, 138.4, 134.2, 133.5, 
131.2, 130.9, 130.7, 130.4, 129.4, 128.6, 127.8, 126.6, 124.6, 120.1, 111.3, 60.1, 55.8, 
37.1 (ppm).  
MS (EI): m/z = 279.7 (100), 452.3 (18, M
+
). 
IR (KBr): 2935, 1700, 1636, 1425, 1335, 1211, 1024, 840, 753 (cm
-1
).  
Anal. calcd for (C24H18Cl2N2O3): C, 63.59; H, 4.00; N, 6.18. Found: C, 63.34; H, 3.98; 
N, 6.02. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(para-methylbenzoyl)-4,5-dihydro 
pyrazole (126ej) 
 
Yield: 92%. Melting point: 109.8-110.8 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 12.5 min; tR (major) = 22.0 min, er 
= 95:5.  
1
H NMR (300 MHz, CDCl3)  = 7.98 (d, J = 8.2 Hz, 2H), 7.53 (d, J = 6.7 Hz, 3H), 
7.40 – 7.37 (m, 1H), 7.34 – 7.26 (m, 5H), 7.04 – 6.95 (m, 2H), 6.11 (dd, J = 12.6, 5.9 
Hz, 1H), 3.83 (s, 3H), 3.69 (dd, J = 17.4, 12.6 Hz, 1H), 3.21 (dd, J = 17.5, 5.9 Hz, 
1H), 2.42 (s, 3H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 193.5, 166.3, 156.7, 153.2, 144.7, 131.7, 131.0, 130.8, 
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130.1, 129.5, 129.0, 128.5, 126.5, 125.2, 120.1, 111.2, 60.2, 55.8, 37.3, 21.7 (ppm).  
MS (EI): m/z = 278.6 (100), 398.2 (64, M
+
). 
IR (KBr): 2931, 1690, 1639, 1600, 1460, 1426, 1234, 1016, 834, 755, 691 (cm
-1
).  
Anal. calcd for (C25H22N2O3): C, 75.36; H, 5.57; N, 7.03. Found: C, 74.93; H, 5.53; N, 
6.81. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(2-furanylcarbonyl)-4,5-dihydro pyrazole 
(126ek) 
 
Yield: 85%. Melting point: 122.8-123.7 oC. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 14.5 min; tR (major) = 26.6 min, er 
= 93:7.  
1
H NMR (600 MHz, CDCl3)  = 7.65 (s, 1H), 7.54 (d, J = 7.2 Hz, 2H), 7.48 (d, J = 
7.5 Hz, 1H), 7.41 – 7.38 (m, 2H), 7.36 – 7.30 (m, 3H), 7.00 (t, J = 7.4 Hz, 1H), 6.96 
(d, J = 8.4 Hz, 1H), 6.58 (t, J = 1.8 Hz, 1H), 5.91 (dd, J = 12.5, 6.2 Hz, 1H), 3.81 (s, 
4H), 3.68 (dd, J = 17.5, 12.6 Hz, 1H), 3.28 (dd, J = 17.5, 6.3 Hz, 1H) (ppm).  
13
C NMR (150 MHz, CDCl3) = 183.2, 166.3, 156.7, 153.5, 150.5, 147.2, 130.9, 
130.2, 129.3, 128.5, 126.5, 125.0, 120.1, 119.1, 112.7, 111.2, 60.4, 55.8, 37.1 (ppm).  
MS (EI): m/z = 279.1 (73), 374.3 (100, M
+
). 
IR (KBr): 2938, 1680, 1637, 1598, 1461, 1425, 1249, 1017, 756, 691 (cm
-1
).  
Anal. calcd for (C22H18N2O4): C, 70.58; H, 4.85; N, 7.48. Found: C, 70.35; H, 4.86; N, 
7.38. 
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(5S)-1-(ortho-Methoxybenzoyl)-3-phenyl-5-(2-thienylcarbonyl)-4,5-dihydro pyrazole 
(126el) 
 
Yield: 88%. Melting point: 118.7-119.5 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 12.8 min; tR (major) = 22.6 min, er 
= 94:6.  
1
H NMR (600 MHz, CDCl3)  = 7.93 (d, J = 3.3 Hz, 1H), 7.71 (d, J = 4.7 Hz, 1H), 
7.55 (d, J = 7.1 Hz, 2H), 7.49 (d, J = 7.4 Hz, 1H), 7.42 – 7.39 (m, 1H), 7.36 – 7.30 (m, 
3H), 7.16 (t, J = 4.8 Hz, 1H), 7.01 (t, J = 7.4 Hz, 1H), 6.97 (d, J = 8.3 Hz, 1H), 5.92 
(dd, J = 12.5, 6.2 Hz, 1H), 3.82 (s, 3H), 3.71 (dd, J = 17.5, 12.5 Hz, 1H), 3.32 (dd, J = 
17.5, 6.2 Hz, 1H) (ppm).  
13
C NMR (150 MHz, CDCl3)  = 187.4, 166.4, 156.7, 153.5, 140.8, 134.9, 133.1, 
131.0, 130.9, 130.2, 129.4, 128.5, 128.4, 126.6, 125.0, 120.1, 111.2, 61.3, 55.8, 37.6 
(ppm).  
MS (EI): m/z = 278.2 (69), 390.2 (100, M
+
). 
IR (KBr): 2936, 1638, 1598, 1460, 1415, 1240, 1021, 756, 692 (cm
-1
).  
Anal. Calcd for (C22H18N2O3S): C, 67.67; H, 4.65; N, 7.17. Found: C, 67.36; H, 4.67; 
N, 6.91. 
 
(5S)-1-Benzoyl-3-(para-chlorophenyl)-5-benzoyl-4,5-dihydro pyrazole (126fa) 
 
Yield: 94%. Melting point: 208.5-209.6 
o
C.  
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
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rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 20.5 min; tR (major) = 24.2 min, er 
= 91:9.  
1
H NMR (600 MHz, CDCl3)  = 8.06 (dd, J = 12.6, 7.5 Hz, 4H), 7.64 – 7.62 (m, 1H), 
7.58 (d, J = 8.5 Hz, 2H), 7.51 (dd, J = 15.5, 7.6 Hz, 3H), 7.45 (t, J = 7.7 Hz, 2H), 7.34 
(d, J = 8.5 Hz, 2H), 6.17 (dd, J = 12.6, 6.3 Hz, 1H), 3.65 (dd, J = 17.4, 12.6 Hz, 1H), 
3.20 (dd, J = 17.4, 6.3 Hz, 1H) (ppm).  
13
C NMR (150 MHz, CDCl3)  = 194.2, 166.3, 152.8, 136.4, 134.3, 133.9, 133.3, 
131.2, 130.1, 129.4, 129.0, 128.9, 128.8, 127.9, 127.7, 60.9, 36.5 (ppm).  
MS (EI): m/z = 282.5 (100), 388.1 (30, M
+
). 
IR (KBr): 3053, 1693, 1607, 1429, 1332, 1227, 825, 700 (cm
-1
).  
Anal. calcd for (C23H17ClN2O2): C, 71.04; H, 4.41; N, 7.20. Found: C, 70.87; H, 4.00; 
N, 7.03. 
 
(5S)-1-Benzoyl-3-(para-fluorophenyl)-5-benzoyl-4,5-dihydro pyrazole (126ga) 
 
Yield: 97%. Melting point: 188.9-190.5 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 16.3 min; tR (major) = 21.8 min, er 
= 90:10.  
1
H NMR (300 MHz, CDCl3)  = 8.09 – 8.04 (m, 4H), 7.67 – 7.60 (m, 3H), 7.54 – 
7.41 (m, 5H), 7.06 (t, J = 8.7 Hz, 2H), 6.17 (dd, J = 12.5, 6.2 Hz, 1H), 3.66 (dd, J = 
17.5, 12.5 Hz, 1H), 3.20 (dd, J = 17.4, 6.2 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.2, 166.3, 165.6, 162.3, 152.8, 134.4, 133.9, 133.4, 
131.2, 130.1, 128.9, 128.8, 128.7, 128.6, 127.7, 127.2, 127.2, 116.0, 115.7, 60.9, 36.7 
(ppm).  
MS (EI): m/z = 265.9 (100), 372.1 (49, M
+
). 
IR (KBr): 3055, 1691, 1606, 1431, 1222, 1155, 837, 700 (cm
-1
).  
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Anal. calcd for (C23H17FN2O2): C, 74.18; H, 4.60; N, 7.52. Found: C, 73.98; H, 4.59; 
N, 7.30. 
 
(5S)-1-Benzoyl-3-(para-methylphenyl)-5-benzoyl-4,5-dihydro pyrazole (126ha) 
 
Yield: 95%. Melting point: 169.0-170.1 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 13.7 min; tR (major) = 15.8 min, er 
= 90:10.  
1
H NMR (300 MHz, CDCl3)  = 8.09 – 8.06 (m, 4H), 7.64 – 7.41 (m, 8H), 7.17 (d, J 
= 8.0 Hz, 2H), 6.13 (dd, J = 12.5, 6.3 Hz, 1H), 3.66 (dd, J = 17.5, 12.5 Hz, 1H), 3.21 
(dd, J = 17.5, 6.3 Hz, 1H), 2.36 (s, 3H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.3, 166.1, 154.0, 140.8, 134.4, 133.8, 133.5, 131.1, 
130.2, 129.4, 128.9, 128.8, 128.1, 127.6, 126.6, 60.9, 36.6, 21.5 (ppm).  
MS (EI): m/z = 262.0 (100), 368.1 (47, M
+
). 
IR (KBr): 3055, 1690, 1606, 1448, 1334, 1226, 817, 701 (cm
-1
). 
Anal. calcd for (C24H20N2O2): C, 78.24; H, 5.47; N, 7.60. Found: C, 77.78; H, 5.38; N, 
7.31. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-(2,4-dichlorophenyl)-5-benzoyl-4,5-dihydro 
pyrazole (126ia) 
 
Yield: 84%. Melting point: 102.6-103.9 
o
C.  
Chapter 2 
117 
 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 12.0 min; tR (major) = 20.2 min, er 
= 93:7.  
1
H NMR (300 MHz, CDCl3)  = 8.07 (d, J = 7.3 Hz, 2H), 7.62 (t, J = 7.3 Hz, 1H), 
7.53 – 7.48 (m, 4H), 7.42 – 7.36 (m, 1H), 7.34 (d, J = 1.8 Hz, 1H), 7.18 – 7.14 (m, 
1H), 7.01 (t, J = 7.5 Hz, 1H), 6.95 (d, J = 8.4 Hz, 1H), 6.14 (dd, J = 12.7, 5.8 Hz, 1H), 
3.94 (dd, J = 17.9, 12.7 Hz, 1H), 3.84 (s, 3H), 3.37 (dd, J = 18.0, 5.8 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 193.8, 166.5, 156.6, 151.6, 136.1, 134.1, 133.8, 133.3, 
131.4, 131.1, 130.4, 129.4, 128.84, 128.82, 128.7, 127.2, 124.7, 120.1, 111.1, 60.6, 
55.8, 39.9 (ppm).  
MS (EI): m/z = 317.0 (100), 422.2 (21). 
IR (KBr): 3069, 1694, 1646, 1420, 1224, 1015, 835, 754, 701 (cm
-1
).  
Anal. calcd for (C24H18Cl2N2O3): C, 63.59; H, 4.00; N, 6.18. Found: C, 63.41; H, 4.04; 
N, 6.05. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-(para-fluorophenyl)-5-benzoyl-4,5-dihydro 
pyrazole (126ja) 
 
Yield: 92%. Melting point: 170.6-171.9 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 13.1 min; tR (major) = 19.3 min, er 
= 94:6.  
1
H NMR (300 MHz, CDCl3)  = 8.07 (dd, J = 8.3, 1.2 Hz, 2H), 7.64 ‐7.58 (m, 1H), 
7.51 ‐7.47 (m, 5H), 7.41 – 7.38 (m, 1H), 7.01 – 6.95 (m, 4H), 6.13 (dd, J = 12.6, 5.9 
Hz, 1H), 3.82 (s, 3H), 3.68 (dd, J = 17.4, 12.6 Hz, 1H), 3.19 (dd, J = 17.4, 5.9 Hz, 1H) 
(ppm).  
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13
C NMR (75 MHz, CDCl3)  = 194.0, 166.2, 165.4, 162.1, 156.7, 152.2, 134.2, 133.8, 
130.9, 129.4, 128.8, 128.8, 128.6, 128.5, 127.3, 127.2, 125.0, 120.1, 115.8, 115.5, 
111.2, 60.3, 55.8, 37.2 (ppm).  
MS (EI): m/z = 297.0 (100), 402.2 (46, M
+
). 
IR (KBr): 2971, 1701, 1634, 1598, 1440, 1222, 840, 758, 699 (cm
-1
).  
Anal. calcd for (C24H19FN2O3): C, 71.63; H, 4.76; N, 6.96. Found: C, 71.24; H, 4.73; 
N, 6.85. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-(para-bromophenyl)-5-benzoyl-4,5-dihydro 
pyrazole (126ka) 
 
Yield: 88%. Melting point: 124.0-124.9 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 16.5 min; tR (major) = 22.2 min, er 
= 88:12.  
1
H NMR (300 MHz, CDCl3)  8.06 (dd, J = 8.4, 1.1 Hz, 2H), 7.64 – 7.58 (m, 1H), 
7.52 – 7.47 (m, 3H), 7.44 – 7.36 (m, 5H), 7.04 – 6.96 (m, 2H), 6.13 (dd, J = 12.6, 6.0 
Hz, 1H), 3.82 (s, 3H), 3.67 (dd, J = 17.5, 12.6 Hz, 1H), 3.18 (dd, J = 17.5, 6.0 Hz, 1H) 
(ppm).  
13
C NMR (75 MHz, CDCl3)  = 193.9, 166.2, 156.7, 152.2, 134.2, 133.8, 131.7, 131.0, 
129.9, 129.4, 128.8, 128.8, 128.0, 124.9, 124.6, 120.1, 111.2, 60.3, 55.8, 37.0 (ppm).  
MS (EI): m/z = 357.1 (100), 463.5 (42, M
+
). 
IR (KBr): 2836, 1694, 1640, 1594, 1428, 1247, 1224, 1005, 827, 755, 699 (cm
-1
).  
Anal. calcd for (C24H19BrN2O3): C, 62.22; H, 4.13; N, 6.05. Found: C, 62.22; H, 4.33; 
N, 5.80. 
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(5S)-1-(ortho-Methoxybenzoyl)-3-(para-chlorophenyl)-5-benzoyl-4,5-dihydro 
pyrazole (126la) 
 
Yield: 96%. Melting point: 169.5-170.3 
o
C.  
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 15.0 min; tR (major) = 20.8 min, er 
= 88:12.  
1
H NMR (300 MHz, CDCl3) =8.06 (dd, J = 8.3, 1.2 Hz, 2H), 7.64 – 7.58 (m, 1H), 
7.52 – 7.38 (m, 6H), 7.27 – 7.24 (m, 2H), 7.04 – 6.96 (m, 2H), 6.13 (dd, J = 12.6, 6.0 
Hz, 1H), 3.82 (s, 3H), 3.67 (dd, J = 17.5, 12.6 Hz, 1H), 3.18 (dd, J = 17.5, 6.0 Hz, 1H) 
(ppm).  
13
C NMR (75 MHz, CDCl3)  = 193.9, 166.2, 156.7, 152.2, 136.1, 134.2, 133.8, 131.0, 
129.5, 129.4, 128.8, 128.8, 128.7, 127.8, 124.9, 120.1, 111.2, 60.3, 55.8, 37.1 (ppm).  
MS (EI): m/z = 312.9 (100), 418.3 (80, M
+
). 
IR (KBr): 2960, 1699, 1635, 1595, 1434, 1401, 1246, 1224, 1008, 835, 758, 695 
(cm
-1
).  
Anal. calcd for (C24H19ClN2O3): C, 68.82; H, 4.57; N, 6.69. Found: C, 68.94; H, 4.62; 
N, 6.55. 
 
(5S)-1-(ortho-Methoxybenzoyl)-3-(para-methoxyphenyl)-5-benzoyl-4,5-dihydro 
pyrazole (126ma) 
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Yield: 86%. Melting point: 154.0-155.2 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 17.6 min; tR (major) = 23.9 min, er 
= 92:8.  
1
H NMR (400 MHz, CDCl3)  = 8.08 (dd, J = 8.3, 1.2 Hz, 2H), 7.65 – 7.60 (m, 1H), 
7.54 – 7.48 (m, 5H), 7.42 – 7.38 (m, 1H), 7.04 – 6.99 (m, 1H), 6.97 (d, J = 8.4 Hz, 
1H), 6.83 (d, J = 8.9 Hz, 2H), 6.11 (dd, J = 12.5, 6.0 Hz, 1H), 3.84 (s, 3H), 3.80 (s, 
3H), 3.68 (dd, J = 17.3, 12.6 Hz, 1H), 3.22 (dd, J = 17.3, 6.0 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.2, 166.0, 161.2, 156.7, 153.1, 134.4, 133.6, 130.8, 
129.5, 128.8, 128.8, 128.2, 125.2, 123.6, 120.1, 113.9, 111.2, 60.3, 55.8, 55.3, 37.3 
(ppm).  
MS (EI): m/z = 309.3 (69), 414.3 (100, M
+
).  
IR (KBr): 2837, 1636, 1600, 1430, 1249, 1019, 834, 755, 703 (cm
-1
).  
Anal. calcd for (C25H22N2O4): C, 72.45; H, 5.35; N, 6.76. Found: C, 72.03; H, 5.53; N, 
6.60. 
 
(5S)-1-(mata-Methoxybenzoyl)-3-methyl-5-benzoyl-4,5-dihydro pyrazole (126na) 
 
Yield: 90%. Melting point: 144.2-145.1 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 1:1, flow 
rate 0.7 mL/min, λ = 254 nm, 20 oC). tR (minor) = 10.8 min; tR (major) = 15.3 min, er 
= 77:23.  
1
H NMR (300 MHz, CDCl3)  = 8.04 (dd, J = 8.3, 1.1 Hz, 2H), 7.60 (t, J = 7.3 Hz, 
1H), 7.49 (t, J = 7.6 Hz, 2H), 7.44 (dd, J = 7.5, 1.7 Hz, 1H), 7.40 – 7.34 (m, 1H), 7.01 
– 6.93 (m, 2H), 5.97 (dd, J = 12.4, 5.9 Hz, 1H), 3.84 (s, 3H), 3.30 (dd, J = 18.0, 12.4 
Hz, 1H), 2.80 (dd, J = 18.0, 5.9 Hz, 1H), 1.95 (s, 3H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.4, 165.6, 156.3, 154.8, 134.3, 133.6, 130.7, 128.9, 
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128.7, 128.7, 125.3, 120.1, 111.3, 59.7, 55.8, 41.1, 15.7 (ppm).  
MS (EI): m/z = 322 (M
+
). 
IR KBr): 2923, 1689, 1633, 1594, 1497, 1455, 1247, 1224, 1021, 834, 748, 709 (cm
-1
). 
Anal. calcd for (C19H18N2O3): C, 70.79; H, 5.63; N, 8.69. Found: C, 70.90; H, 5.78; N, 
8.74. 
 
(5S)-1-(mata-Methoxybenzoyl)-3-tert-butyl-5-benzoyl-4,5-dihydro pyrazole (126oa) 
 
Yield: 93%. Melting point: 51-52 
o
C. 
The er was determined by HPLC (Chiralpak OD column, hexane/i-PrOH 7:3, flow 
rate 1.0 mL/min, λ = 254 nm, 20 oC). tR (minor) = 8.7 min; tR (major) = 14.6 min, er = 
79:21.  
1
H NMR (400 MHz, CDCl3)  = 8.04 (d, J = 7.8 Hz, 2H), 7.60 (t, J = 7.2 Hz, 1H), 
7.50 – 7.45 (m, 1H), 7.36 (t, J = 7.8 Hz, 1H), 6.97 (t, J = 7.4 Hz, 2H), 6.91 (d, J = 8.3 
Hz, 1H), 5.95 (dd, J = 12.3, 5.8 Hz, 1H), 3.83 (s, 3H), 3.33 (dd, J = 17.6, 12.5 Hz, 
1H), 2.84 (dd, J = 17.6, 5.8 Hz, 1H), 1.10 (s, 9H) (ppm).  
13
C NMR (100 MHz, CDCl3)  = 194.5, 165.9, 164.4, 156.6, 134.4, 133.5, 130.7, 
129.5, 128.8, 128.7, 125.1, 119.9, 110.9, 60.1, 55.6, 36.5, 33.9, 27.9 (ppm).  
MS (EI): m/z = 364 (M
+
). 
IR (KBr): 2965, 1642, 1600, 1438, 1252, 1224, 841, 754, 705, 657 (cm
-1
).  
HRMS (EI): m/z calcd for C22H25N2O3: 365.1860 [M+H]
+
; found: 365.1855. 
 
 (5S)-1-(mata-Methoxybenzoyl)-3-iso-buyl-5-benzoyl-4,5-dihydro pyrazole (126pa) 
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Yield: 84%. Melting point: 85-86 
o
C. 
The er was determined by HPLC (Chiralpak OD column, hexane/i-PrOH 7:3, flow 
rate 1.0 mL/min, λ = 254 nm, 20 oC). tR (minor) = 13.0 min; tR (major) = 17.5 min, er 
= 87:13.  
1
H NMR (400 MHz, CDCl3)  = 8.03 (d, J = 7.8 Hz, 2H), 7.58 (t, J = 7.3 Hz, 1H), 
7.49 – 7.43 (m, 3H), 7.36 (t, J = 7.9 Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 6.92 (d, J = 8.3 
Hz, 1H), 5.95 (dd, J = 12.3, 5.7 Hz, 1H), 3.81 (s, 3H), 3.27 (dd, J = 17.8, 12.5 Hz, 
1H), 2.76 (dd, J = 17.9, 5.6 Hz, 1H), 2.14 (d, J = 7.2 Hz, 2H), 1.86 – 1.79 (m, 1H), 
0.89 (d, J = 6.5 Hz, 6H) (ppm).  
13
C NMR (100 MHz, CDCl3)  = 194.4, 165.7, 157.5, 156.3, 134.3, 133.5, 130.7, 
129.0, 128.7, 128.6, 125.2, 120.0, 110.9, 59.4, 55.5, 39.8, 38.6, 26.2, 22.2, 22.1 
(ppm).  
MS (EI): m/z = 364 (M
+
). 
IR (KBr): 2957, 2927, 1694, 1641, 1495, 1461, 1251, 1221, 1020, 754, 695, 652 
(cm
-1
).  
HRMS (EI): m/z calcd for C22H25N2O3: 365.1860 [M+H]
+
; found: 365.1851. 
 
(5S)-1-(mata-Methoxybenzoyl)-3-phenylethyl-5-benzoyl-4,5-dihydro pyrazole 
(126qa) 
 
Yield: 93%. Melting point: 46-47 
o
C. 
The er was determined by HPLC (Chiralpak OD column, hexane/i-PrOH 7:3, flow 
rate 1.0 mL/min, λ = 254 nm, 20 oC). tR (minor) = 23.6 min; tR (major) = 37.7 min, er 
= 87:13.  
1
H NMR (400 MHz, CDCl3)  8.00 (d, J = 7.6 Hz, 2H), 7.59 (t, J = 7.3 Hz, 1H), 
7.48 (t, J = 7.5 Hz, 2H), 7.42 – 7.36 (m, 2H), 7.24 – 7.14 (m, 3H), 7.10 (d, J = 7.3 Hz, 
2H), 7.00 (t, J = 7.4 Hz, 1H), 6.94 (d, J = 8.3 Hz, 1H), 5.93 (dd, J = 12.4, 5.8 Hz, 1H), 
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3.82 (s, 3H), 3.21 (dd, J = 17.8, 12.5 Hz, 1H), 2.80 (t, J = 7.4 Hz, 2H), 2.72 (dd, J = 
17.9, 5.7 Hz, 1H), 2.58 (t, J = 7.3 Hz, 2H) (ppm).  
13
C NMR (100 MHz, CDCl3)  = 194.3, 165.8, 157.3, 156.4, 140.4, 134.3, 133.6, 
130.8, 129.2, 128.8, 128.7, 128.4, 128.3, 126.2, 125.1, 120.1, 111.1, 59.6, 55.7, 39.90, 
32.3, 31.6 (ppm).  
MS (EI): m/z = 412 (M
+
). 
IR (KBr): 2930, 1643, 1599, 1466, 1446, 1250, 1222, 754, 701, 654 (cm
-1
).  
HRMS (EI): m/z calcd for C26H25N2O3: 413.1860 [M+H]
+
; found: 413.1851. 
 
(5S)-1-(mata-Methoxybenzoyl)-3-ethyl carbonyl ester-5-benzoyl-4,5-dihydro 
pyrazole (126ra) 
 
Yield: 93%. Melting point: 56-57 oC. 
The er was determined by HPLC (Chiralpak OD column, hexane/i-PrOH 7:3, flow 
rate 1.0 mL/min, λ = 254 nm, 20 oC). tR (minor) = 20.1 min; tR (major) = 37.1 min, er 
= 93:7.  
1
H NMR (400 MHz, CDCl3)  = 8.03 (d, J = 7.8 Hz, 2H), 7.63 (t, J = 7.1 Hz, 1H), 
7.53 – 7.48 (m, 3H), 7.41 (t, J = 7.9 Hz, 1H), 7.01 (t, J = 7.5 Hz, 1H), 6.97 (d, J = 8.4 
Hz, 1H), 6.11 (dd, J = 12.9, 6.2 Hz, 1H), 4.24 (dd, J = 13.9, 6.8 Hz, 2H), 3.85 (s, 3H), 
3.56 (dd, J = 18.4, 13.2 Hz, 1H), 3.12 (dd, J = 18.6, 6.1 Hz, 1H), 1.26 (t, J = 7.0 Hz, 
3H) (ppm).  
13
C NMR (100 MHz, CDCl3)  = 193.0, 167.2, 161.2, 156.9, 146.1, 134.0, 133.7, 
131.6, 129.6, 128.9, 128.8, 123.7, 120.3, 111.6, 61.8, 61.0, 55.9, 36.8, 14.0 (ppm).  
MS (EI): m/z = 380 (M
+
). 
IR KBr): 2980, 1700, 1663, 1598, 1464, 1447, 1318, 1251, 1102, 1019, 849, 757, 702, 
654 (cm
-1
).  
HRMS (EI): m/z calcd for C21H21N2O5: 381.1445 [M+H]
+
; found: 381.1433. 
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(5S)-1-(mata-Methoxybenzoyl)-3-E-phenylethenyl-5-benzoyl-4,5-dihydro pyrazole 
(126sa) 
 
Yield: 92%. Melting point: 134-135 
o
C. 
The er was determined by HPLC (Chiralpak OD column, hexane/i-PrOH 1:1, flow 
rate 1.0 mL/min, λ = 254 nm, 20 oC). tR (minor) = 23.1 min; tR (major) = 32.8 min, er 
= 71:29.  
1
H NMR (400 MHz, CDCl3) = 8.06 (d, J = 7.9 Hz, 2H), 7.61 (t, J = 7.3 Hz, 1H), 
7.50 (t, J = 8.0 Hz, 3H), 7.41 – 7.34 (m, 3H), 7.29 – 7.25 (m, 3H), 7.02 (d, J = 7.5 Hz, 
1H), 6.99 – 6.91 (m, 2H), 6.66 (d, J = 16.5 Hz, 1H), 6.06 (dd, J = 12.6, 5.9 Hz, 1H), 
3.83 (s, 3H), 3.54 (dd, J = 17.1, 12.7 Hz, 1H), 3.08 (dd, J = 17.1, 5.8 Hz, 1H) (ppm).  
13
C NMR (100 MHz, CDCl3)  = 193.8, 166.1, 156.4, 154.4, 137.0, 135.5, 134.1, 
133.7, 131.0, 129.1, 128.9, 128.8, 128.8, 126.9, 124.9, 120.6, 120.2, 111.3, 60.1, 55.8, 
36.0 (ppm).  
MS (EI): m/z = 410 (M
+
). 
IR (KBr): 3057, 2935, 1697, 1645, 1598, 1463, 1432, 1340, 1249, 1224, 1020, 840, 
752, 692, 652 (cm
-1
).  
HRMS (EI): m/z calcd for C26H23N2O3: 411.1703 [M+H]
+
; found: 411.1690. 
 
(5S)-1-(meta-Methoxybenzoyl)-3-phenyl-5-benzoyl-4,5-dihydro pyrazole (126ta) 
 
Yield: 88%. Melting point: 126.9-128.0 oC. 
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The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 19.0 min; tR (major) = 25.7 min, er 
= 92:8.  
1
H NMR (300 MHz, CDCl3)  = 8.07 (d, J = 7.1 Hz, 2H), 7.72 (d, J = 7.7 Hz, 1H), 
7.67 – 7.59 (m, 4H), 7.51 – 7.47 (m, 2H), 7.39 – 7.33 (m, 4H), 7.07 – 7.03 (m, 1H), 
6.14 (dd, J = 12.5, 6.3 Hz, 1H), 3.84 (s, 3H), 3.67 (dd, J = 17.5, 12.5 Hz, 1H), 3.21 
(dd, J = 17.5, 6.3 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.3, 165.9, 158.9, 154.0, 134.6, 134.4, 133.8, 130.8, 
130.4, 128.9, 128.8, 128.7, 128.6, 126.6, 122.7, 117.8, 114.7, 60.9, 55.3, 36.5 (ppm).  
MS (EI): m/z = 384 (M
+
). 
IR (KBr): 2948, 1689, 1612, 1570, 1440, 1332, 1221, 768, 685 (cm
-1
).  
Anal. calcd for (C24H20N2O3): C, 74.98; H, 5.24; N, 7.29. Found: C, 74.85; H, 4.91; N, 
7.15. 
 
(5S)-1-(para-Methoxybenzoyl)-3-phenyl-5-benzoyl-4,5-dihydro pyrazole (126ua) 
 
Yield: 88%. Melting point: 173.8-174.7 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 20.2 min; tR (major) = 34.5 min, er 
= 91:9.  
1
H NMR (300 MHz, CDCl3)  = 8.16 (d, J = 9.1 Hz, 2H), 8.07 (dd, J = 8.4, 1.3 Hz, 
2H), 7.69 – 7.59 (m, 3H), 7.52 – 7.48 (m, 2H), 7.39 – 7.37 (m, 3H), 6.94 (d, J = 9.1 
Hz, 2H), 6.14 (dd, J = 12.5, 6.5 Hz, 1H), 3.85 (s, 3H), 3.64 (dd, J = 17.5, 12.5 Hz, 
1H), 3.19 (dd, J = 17.5, 6.5 Hz, 1H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.6, 165.4, 162.0, 153.6, 134.5, 133.7, 132.4, 131.0, 
130.3, 128.8, 128.8, 128.6, 126.6, 125.5, 112.9, 61.0, 55.3, 36.4 (ppm).  
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MS (EI): m/z = 384 (M
+
). 
IR (KBr): 2842, 1685, 1599, 1422, 1334, 1256, 1229, 1021, 838, 754, 687 (cm
-1
).  
Anal. calcd for (C24H20N2O3): C, 74.98; H, 5.24; N, 7.29. Found: C, 74.92; H, 5.01; N, 
7.09. 
 
(5S)-1-(para-Methylbenzoyl)-3-phenyl-5-benzoyl-4,5-dihydro pyrazole (126va) 
 
Yield: 97%. Melting point: 165.3-166.3 
o
C. 
The er was determined by HPLC (Chiralpak OD column, heptane/i-PrOH 7:3, flow 
rate 0.8 mL/min, λ = 254 nm, 20 oC). tR (minor) = 14.9 min; tR (major) = 20.6 min, er 
= 90:10.  
1
H NMR (300 MHz, CDCl3)  = 8.09 (d, J = 7.1 Hz, 2H), 8.02 (d, J = 8.1 Hz, 2H), 
7.70 – 7.66 (m, 2H), 7.62 (d, J = 6.9 Hz, 1H), 7.53 (t, J = 7.8 Hz, 2H), 7.42 – 7.38 (m, 
3H), 7.30 – 7.21 (m, 3H), 6.16 (dd, J = 12.5, 6.4 Hz, 1H), 3.68 (dd, J = 17.5, 12.5 Hz, 
1H), 3.24 (dd, J = 17.4, 6.4 Hz, 1H), 2.42 (s, 3H) (ppm).  
13
C NMR (75 MHz, CDCl3)  = 194.5, 166.2, 153.6, 141.6, 134.5, 133.8, 131.0, 130.5, 
130.4, 130.3, 128.9, 128.8, 128.6, 128.4, 126.6, 60.9, 36.5, 21.5 (ppm).  
MS (EI): m/z = 368 (M
+
). 
IR (KBr): 2324, 1688, 1617, 1427, 1330, 1219, 778, 686 (cm
-1
).  
Anal. Calcd for (C24H20N2O2): C, 78.24; H, 5.47; N, 7.60. Found: C, 78.12; H, 5.18; 
N, 7.52. 
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Appendix 
 
1 List of Abbreviations 
 
Å Angstrom 
Ac acetyl 
aq. aqueous (solution) 
Ar aromatic substituent 
Bn benzyl 
br broad (NMR signal) 
Bu butyl 
t-Bu tert-butyl 
Calc. calculated 
C centigrade 
Cy cyclohexyl 
 chemical shift 
d doublet (NMR signal) 
DCE dichloroethane 
DCM dichloromethane 
DMF N,N-dimethylformamide 
DMSO dimethylsulfoxide 
Ed. edition 
EI electronic impact (in mass spectroscopy) 
Et ethyl 
eV electron volt 
GC gas chromatography 
HRMS high resolution mass spectroscopy 
Hz Hertz 
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IR infrared spectroscopy 
J coupling constant (in NMR spectroscopy) 
L ligand 
M metal 
m-CPBA 3-chloroperoxybenzoic acid 
Me methyl 
min minutes 
mol mole 
MS mass spectroscopy 
NMR nuclear magnetic resonance (spectroscopy) 
iPr iso-propyl 
rt room temperature 
s singlet (NMR signal) 
TBHP tert-Butylhydroperoxide 
Temp. temperature 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMS trimethylsilyl 
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